rfhg_190924.1

Basic information about the TSS

---

TSS ID: rfhg_190924.1 TSS ID(Version3): hg_164920.1 hg_164918.1 hg_164917.1 hg_164919.1 hg_226583.1 Species: human Chr: chr17		Start: 21042811 End: 21043056 Strand: -
Source datasets
Protocol
TSS cluster detected*

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	-
Category:	-

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000261497.9:0 AB028986:0 AB590105:0 GeneID: 23326 HGNC/MGI_ID: HGNC:12621 UniProt_ID: Q9UPT9 Nearer transcript ids and distances:

Gene_name: ubiquitin specific peptidase 22 Gene_symbol: USP22 Gene_synonyms: KIAA1063 Gene_source: HGNC:12621

TATA-Box annotation

---

Distance to TSS:	105
Nearest PromoterID:	ENST00000261497.8
Entrez ID:	ENSG00000124422
Nearest Unigene:	ENST00000582335
Nearest Refseq:
Nearest Ensembl:
Gene Name:	ubiquitin specific peptidase 22
Gene Alias:
Gene Type:	protein_coding
CpG%:	0.139344
GC%:	0.783673
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@USP22 p2@USP22 p3@USP22 p4@USP22 p5@USP22 p8@USP22
Sample		p1@USP22	p2@USP22	p3@USP22	p4@USP22	p5@USP22	p8@USP22
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	100.52	24.93	13.83	3.90	2.73	0.58
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	109.45	28.93	12.95	5.46	2.23	0.20
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	114.58	27.97	17.17	5.21	2.31	0.39
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	80.05	17.46	9.77	3.95	1.87	0.62
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	88.19	20.02	16.42	5.40	2.25	0.22
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	84.11	19.77	14.15	4.46	3.10	0.97
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	91.95	30.50	22.44	4.79	2.40	0.44
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	80.66	23.98	19.86	3.15	2.18	0.48
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	90.62	26.50	19.66	4.06	1.50	0.64
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	81.15	33.04	23.76	8.11	0.58	0.58
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	80.85	34.76	28.30	4.45	4.04	1.21
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	76.84	35.78	23.17	6.10	1.22	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	98.01	11.28	7.09	1.77	2.26	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	81.79	7.07	5.71	1.95	1.95	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	82.55	12.51	6.81	1.98	1.76	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	90.03	11.07	5.03	3.27	4.02	0.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	86.27	6.99	8.52	0.87	1.09	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	90.69	9.70	5.48	1.69	2.95	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	87.44	5.33	5.86	1.07	1.07	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	72.36	8.27	4.06	0.90	3.61	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	87.41	10.02	6.68	2.00	1.60	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	79.58	11.05	4.14	1.55	3.11	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	85.83	9.82	4.52	2.07	2.07	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	83.48	9.22	5.34	4.13	0.97	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	93.39	10.84	6.19	2.84	1.81	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	81.98	7.28	2.85	1.90	2.53	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	81.32	9.34	7.69	1.10	2.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	90.29	15.09	4.95	1.89	4.01	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	73.65	8.56	4.52	1.78	2.42	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	83.24	9.41	6.33	1.45	2.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	77.25	10.05	4.81	2.72	1.26	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	76.20	10.16	7.03	2.15	1.56	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	84.20	11.18	5.28	2.53	2.11	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	82.47	5.11	6.10	1.98	2.97	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	72.55	9.72	5.80	1.50	1.87	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	80.48	11.31	4.98	1.34	2.30	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	73.99	10.01	7.36	2.45	2.66	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	78.18	9.07	3.43	2.01	2.42	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	80.76	8.64	6.75	1.89	2.43	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	80.18	9.12	5.04	1.20	1.92	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	77.17	10.35	4.47	2.35	2.35	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	83.15	7.32	3.51	2.20	2.49	0.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	76.98	12.02	7.59	1.90	1.69	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	80.07	11.19	5.77	1.92	2.80	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	82.92	14.05	8.43	1.81	1.41	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	76.54	12.33	8.14	2.79	1.86	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	87.81	12.00	6.72	1.92	1.68	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	78.39	9.24	4.17	2.38	1.49	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	81.39	11.49	7.90	1.91	2.39	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	79.26	9.10	6.07	2.22	1.62	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	75.42	9.43	3.28	0.82	0.82	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	88.06	13.12	8.67	1.78	2.22	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	83.95	0.00	0.00	0.00	153.91	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	105.39	11.00	8.52	2.13	2.48	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	88.81	12.26	10.94	1.99	0.66	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	93.12	3.36	1.68	1.68	9.23	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	70.72	5.51	5.05	0.92	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	93.99	13.61	8.10	0.97	1.94	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	100.20	18.63	10.28	1.28	2.89	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	62.55	5.34	4.09	2.83	3.77	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	100.82	17.63	11.28	1.41	4.23	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	101.50	14.02	8.41	1.68	2.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	78.02	5.57	1.59	3.18	6.37	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	60.48	6.46	4.76	1.02	2.38	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	87.40	15.60	6.82	1.62	1.30	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	84.84	10.29	7.10	1.77	2.13	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	32.33	0.00	0.00	0.00	193.97	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	86.87	0.00	0.00	7.90	78.97	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	63.86	9.75	6.34	0.49	2.44	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	42.15	9.42	4.96	3.47	0.50	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	48.32	9.38	2.81	0.94	0.94	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	45.70	3.31	3.97	0.66	3.31	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	59.39	9.59	5.88	0.62	1.55	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	56.56	13.15	6.42	1.22	1.22	0.00
Adipocyte - breast, donor1	11376-118A8	72.22	6.02	2.38	3.96	1.74	0.32
Adipocyte - breast, donor2	11327-117E4	68.18	6.42	3.05	2.25	2.89	0.00
Adipocyte - omental, donor1	11473-119C6	84.48	8.14	4.07	4.07	1.02	0.38
Adipocyte - omental, donor2	11474-119C7	58.30	4.48	3.74	1.49	1.49	1.49
Adipocyte - omental, donor3	11475-119C8	62.63	7.03	2.34	3.35	2.68	0.33
Adipocyte - perirenal, donor1	11476-119C9	56.78	6.38	3.83	3.19	4.47	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	26.39	5.50	2.20	1.10	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	43.36	2.71	2.71	3.16	0.00	0.90
Adipocyte - subcutaneous, donor3	11408-118E4	65.17	8.17	3.48	2.43	2.61	0.87
Adipocyte differentiation, day04, donor1	13019-139D4	101.11	7.43	2.93	4.50	3.13	0.00
Adipocyte differentiation, day04, donor2	13022-139D7	81.33	6.43	2.83	3.35	0.51	0.51
Adipocyte differentiation, day04, donor3	13025-139E1	73.32	6.97	3.35	2.23	0.56	0.56
Adipocyte differentiation, day04, donor4	13028-139E4	87.58	8.23	4.11	1.18	0.59	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	100.70	9.01	3.54	6.52	2.49	0.56
Adipocyte differentiation, day08, donor2	13023-139D8	70.36	5.81	2.58	2.58	2.58	0.32
Adipocyte differentiation, day08, donor3	13026-139E2	61.85	4.27	3.20	3.73	2.67	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	70.67	3.34	1.67	2.23	0.56	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	74.44	9.15	4.99	3.33	1.66	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	73.84	6.78	4.02	2.26	2.51	0.75
Adipocyte differentiation, day12, donor3	13027-139E3	82.79	10.14	4.91	5.89	0.98	0.33
Adipocyte differentiation, day12, donor4	13030-139E6	55.11	5.78	2.74	3.04	1.52	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	87.96	13.48	5.97	2.65	1.33	0.22
Alveolar Epithelial Cells, donor2	11590-120G6	54.86	8.96	5.02	1.43	0.36	0.72
Alveolar Epithelial Cells, donor3	11671-122G6	52.71	10.78	1.20	1.20	3.59	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	91.21	12.05	6.66	4.14	1.26	0.54
Amniotic Epithelial Cells, donor2	11613-122A2	71.96	3.35	6.69	1.67	6.69	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	107.65	11.71	7.40	2.26	1.23	0.82
Anulus Pulposus Cell, donor1	11248-116E6	119.00	6.64	5.38	2.40	1.60	0.11
Anulus Pulposus Cell, donor2	11463-119B5	97.96	7.10	3.43	2.45	0.49	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	63.80	4.04	2.70	1.35	0.90	0.45
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	75.54	4.78	4.34	2.60	0.00	1.74
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	44.95	2.14	0.00	0.00	2.14	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	63.37	5.68	2.39	2.39	1.20	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	61.97	1.26	2.53	2.53	2.53	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	38.94	1.98	1.98	4.62	2.64	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	54.58	6.82	2.60	4.22	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	53.88	3.88	3.40	3.88	1.46	0.49
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	43.95	8.91	1.19	4.16	3.56	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	62.52	4.90	2.26	2.26	0.75	0.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	62.41	7.98	0.73	3.63	0.00	0.73
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	57.67	1.25	1.25	3.76	3.76	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	57.33	4.61	3.95	2.80	1.32	0.33
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	61.42	5.46	4.09	1.36	1.36	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	51.87	3.77	1.81	2.11	3.92	0.30
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	57.33	5.36	3.75	1.07	5.36	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	68.39	6.05	3.21	4.35	5.29	0.19
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	67.36	4.01	4.28	2.94	5.08	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	72.18	3.90	0.98	5.85	2.93	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	54.57	4.64	1.99	2.82	3.32	0.17
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	32.42	3.60	1.20	3.60	4.80	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	63.72	10.62	3.54	3.54	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	62.27	4.29	3.60	4.63	2.23	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	33.56	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	67.47	3.88	2.91	2.91	2.91	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	61.09	4.93	3.42	4.55	1.52	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	55.72	1.21	2.42	2.42	7.27	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	50.16	6.84	2.85	1.71	5.13	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	55.58	5.34	2.57	3.21	3.63	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	61.17	3.10	2.06	2.84	1.55	0.52
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	55.84	4.69	4.22	0.94	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	61.09	5.14	1.29	5.79	3.54	0.32
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	46.37	2.85	2.14	2.14	1.43	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	45.04	7.60	2.34	1.75	2.34	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	60.82	6.62	2.71	3.31	6.32	0.60
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	55.84	4.75	3.56	2.38	2.38	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	53.40	2.54	1.53	3.05	1.53	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	52.72	5.09	2.29	2.80	2.55	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	47.65	0.64	4.45	5.08	4.45	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	52.65	6.04	2.59	4.75	2.59	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	56.10	5.72	2.96	2.12	1.91	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	47.85	2.90	2.32	2.90	4.35	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	58.57	1.89	3.78	4.72	1.89	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	55.27	4.92	1.86	3.05	4.07	0.34
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	37.06	9.27	4.63	4.63	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	71.83	0.00	4.23	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	59.61	6.22	1.50	3.00	3.22	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	52.95	3.61	0.60	1.20	1.80	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	47.38	5.10	2.19	1.46	1.46	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	57.93	4.60	3.68	4.14	3.45	0.23
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	68.86	2.55	0.00	2.55	2.55	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	49.32	1.78	3.05	3.81	3.81	0.25
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	67.30	5.78	3.51	4.75	3.10	0.83
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	51.71	5.51	2.75	3.67	2.14	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	60.23	3.35	3.82	3.35	1.43	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	68.07	5.99	3.10	2.66	4.43	0.44
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	50.35	3.05	1.53	4.58	9.15	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	47.08	4.43	3.32	2.77	0.55	0.55
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	58.52	6.88	3.44	2.38	3.97	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	49.79	5.45	1.09	3.27	2.18	0.00
Astrocyte - cerebellum, donor1	11500-119F6	156.71	12.40	11.67	7.86	0.86	1.11
Astrocyte - cerebellum, donor2	11580-120F5	163.80	14.72	7.87	6.33	1.54	0.68
Astrocyte - cerebellum, donor3	11661-122F5	118.30	9.44	5.66	7.76	3.57	0.42
Astrocyte - cerebral cortex, donor1	11235-116D2	86.10	11.15	8.37	11.85	2.09	0.35
Astrocyte - cerebral cortex, donor2	11316-117D2	127.64	13.75	6.47	16.82	3.88	0.81
Astrocyte - cerebral cortex, donor3	11392-118C6	100.24	14.47	7.01	14.17	2.68	0.75
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	125.92	12.84	4.47	1.03	1.38	0.46
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	128.16	12.28	3.51	1.13	1.00	0.50
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	125.18	12.63	5.12	1.02	1.37	0.11
Basophils, donor1	12241-129G9	47.08	3.14	1.05	2.09	1.31	1.05
Basophils, donor2	12242-129H1	69.99	2.53	2.89	3.61	1.08	2.53
Basophils, donor3	12243-129H2	49.69	3.82	2.06	1.32	0.73	0.88
Bronchial Epithelial Cell, donor1	11511-119G8	61.66	9.27	4.31	1.51	0.43	0.22
Bronchial Epithelial Cell, donor2	11591-120G7	58.52	7.31	6.86	0.46	0.46	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	50.21	14.35	7.17	0.00	7.17	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	64.02	6.90	1.26	0.00	0.00	1.88
Bronchial Epithelial Cell, donor5	11457-119A8	75.90	9.98	5.82	2.70	1.25	0.21
Bronchial Epithelial Cell, donor6	11461-119B3	68.86	12.44	5.07	1.84	1.84	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	41.21	7.56	4.14	0.72	1.62	0.36
Burkitt's lymphoma cell line:DAUDI	10422-106C8	103.88	14.43	10.00	1.13	2.16	0.10
Burkitt's lymphoma cell line:RAJI	10476-106I8	111.10	14.67	9.08	0.93	1.40	0.70
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	152.21	9.91	6.08	2.88	2.88	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	299.92	10.34	10.34	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	44.52	2.82	1.13	1.69	2.25	0.56
CD14+ Monocytes, donor2	11305-117B9	67.93	2.97	2.23	1.48	0.74	0.19
CD14+ Monocytes, donor3	11381-118B4	52.91	2.41	1.32	2.20	1.32	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	74.16	6.51	4.81	1.13	3.11	0.85
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	75.81	8.72	3.03	1.52	1.52	1.52
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	80.87	9.53	3.62	0.33	1.31	0.33
CD14+ monocytes - mock treated, donor1	11863-125A9	73.29	6.50	1.59	1.16	1.30	1.30
CD14+ monocytes - mock treated, donor2	11873-125C1	48.58	5.13	2.11	0.30	0.30	0.30
CD14+ monocytes - mock treated, donor3	11883-125D2	64.43	4.97	4.26	0.71	0.95	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	41.35	5.19	1.84	0.67	1.51	2.01
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	29.53	4.69	2.76	0.28	0.00	0.55
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	30.99	3.97	1.24	0.50	0.50	2.48
CD14+ monocytes - treated with BCG, donor1	11860-125A6	26.82	3.33	0.59	0.39	0.78	1.17
CD14+ monocytes - treated with BCG, donor2	11870-125B7	27.42	0.89	1.60	0.53	0.53	0.18
CD14+ monocytes - treated with BCG, donor3	11880-125C8	23.72	1.74	0.87	0.44	0.44	1.09
CD14+ monocytes - treated with Candida, donor1	11868-125B5	24.12	1.64	0.94	0.23	0.47	2.11
CD14+ monocytes - treated with Candida, donor2	11878-125C6	31.68	1.06	0.53	0.00	0.53	0.53
CD14+ monocytes - treated with Candida, donor3	11888-125D7	29.95	0.00	1.11	3.33	3.33	2.22
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	48.34	4.61	2.83	0.45	1.19	2.53
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	34.52	5.59	2.00	1.20	0.20	0.80
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	30.19	1.25	1.25	0.21	0.00	0.83
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	24.48	3.66	0.69	1.14	0.92	0.69
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	20.36	3.17	1.13	0.00	0.23	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	20.08	2.62	0.87	0.00	0.00	0.44
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	43.58	2.69	1.08	1.08	0.54	1.88
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	50.42	3.84	1.74	0.52	0.87	0.70
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	54.71	1.26	2.95	1.26	0.00	2.52
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	16.90	2.20	1.10	0.18	0.18	2.39
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	17.97	1.06	1.41	0.00	0.00	1.06
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	20.62	1.75	0.88	0.44	0.00	1.75
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	32.96	1.92	1.22	0.52	0.17	2.09
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	31.22	2.97	0.74	0.74	0.74	0.74
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	27.59	1.29	1.29	0.65	0.43	1.51
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	17.61	2.05	0.00	0.00	1.64	1.23
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	14.14	0.93	1.16	0.23	0.00	0.23
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	12.53	1.39	0.93	0.00	0.70	1.86
CD14+CD16+ Monocytes, donor1	11789-124B7	26.59	0.65	1.53	1.09	0.00	0.22
CD14+CD16+ Monocytes, donor2	11801-124D1	36.96	0.69	0.69	2.08	0.00	0.69
CD14+CD16+ Monocytes, donor3	11912-125G4	34.23	2.38	1.95	1.08	0.22	0.65
CD14+CD16- Monocytes, donor1	11788-124B6	82.07	4.05	2.65	1.25	0.31	0.62
CD14+CD16- Monocytes, donor2	11799-124C8	60.43	1.57	2.97	0.70	0.52	1.05
CD14+CD16- Monocytes, donor3	11910-125G2	85.40	6.47	4.24	2.01	0.22	0.89
CD14-CD16+ Monocytes, donor1	11790-124B8	38.28	2.30	1.02	2.04	0.51	1.02
CD14-CD16+ Monocytes, donor2	11800-124C9	36.67	1.10	0.66	1.32	0.44	1.98
CD14-CD16+ Monocytes, donor3	11911-125G3	29.69	1.68	0.63	0.84	0.63	0.84
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	58.94	4.06	4.06	0.00	2.03	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	83.39	4.75	2.71	1.36	0.00	2.03
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	63.17	3.11	2.07	0.00	2.07	1.04
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	99.15	4.80	2.13	3.20	4.80	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	71.83	1.61	1.07	1.61	0.54	1.07
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	76.51	4.21	0.00	0.00	0.00	2.11
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	76.08	5.49	3.14	0.00	0.00	1.57
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	89.64	5.27	0.00	1.32	3.95	2.64
CD19+ B Cells, donor1	11544-120B5	200.54	16.44	4.93	0.82	2.47	0.82
CD19+ B Cells, donor2	11624-122B4	155.24	4.35	2.18	0.73	0.73	0.00
CD19+ B Cells, donor3	11705-123B4	142.87	4.04	1.51	1.51	1.01	3.03
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	47.27	5.66	3.64	0.40	1.21	10.51
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	33.96	4.39	2.80	0.40	1.60	5.19
CD34+ Progenitors, donor1	11545-120B6	174.70	6.02	1.00	6.02	1.00	0.00
CD34+ Progenitors, donor2	11625-122B5	107.87	5.06	2.25	3.37	2.25	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	124.37	11.65	5.26	3.76	1.13	1.13
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	118.38	6.54	4.74	1.35	2.25	0.90
CD4+ T Cells, donor1	11225-116C1	146.75	8.21	5.36	2.14	1.07	1.07
CD4+ T Cells, donor2	11306-117C1	138.39	5.51	2.45	1.84	1.84	2.45
CD4+ T Cells, donor3	11382-118B5	122.91	6.40	3.96	2.44	2.74	1.22
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	69.17	1.79	1.02	0.00	0.26	0.51
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	82.43	4.27	1.12	0.45	1.12	0.22
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	94.00	3.16	2.01	0.29	1.72	0.57
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	128.00	3.79	0.95	0.95	0.95	3.32
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	113.78	3.51	5.62	1.40	0.00	2.11
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	92.29	6.59	6.59	3.30	0.00	6.59
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	61.85	1.45	1.45	0.72	0.14	0.43
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	80.83	3.90	1.36	0.34	1.53	0.51
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	75.28	3.55	1.45	0.81	2.58	0.32
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	76.66	2.69	1.79	2.24	0.45	1.79
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	75.82	2.45	0.70	1.05	1.75	1.05
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	78.32	1.76	1.32	1.76	0.88	1.76
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	82.64	2.53	0.84	1.26	0.84	1.69
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	89.13	4.16	0.42	1.04	2.08	0.83
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	84.53	3.01	1.67	0.67	4.01	0.33
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	121.01	5.17	3.26	1.09	1.36	3.54
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	152.75	10.72	4.29	0.54	0.54	3.22
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	98.63	3.59	5.38	1.79	0.00	3.59
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	91.05	2.41	1.11	0.56	0.56	0.56
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	72.35	3.03	1.30	0.00	0.87	1.52
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	67.25	1.89	1.26	0.21	0.63	0.63
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	68.76	1.52	1.01	1.52	0.00	2.02
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	64.55	2.60	2.17	0.00	0.43	0.87
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	66.68	2.18	2.18	0.87	0.87	0.87
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	87.10	2.97	2.47	0.00	0.00	1.48
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	65.55	2.77	2.77	0.00	1.85	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	64.21	2.79	1.40	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	97.76	1.38	1.38	1.38	0.28	0.83
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	93.25	4.66	1.72	0.74	0.74	0.74
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	121.66	1.54	3.08	0.00	1.54	4.62
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	84.87	3.22	1.07	0.72	0.00	0.72
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	84.48	1.38	0.00	0.00	0.00	4.15
CD8+ T Cells, donor1	11226-116C2	109.35	3.60	1.96	4.58	1.31	1.96
CD8+ T Cells, donor2	11307-117C2	107.00	3.38	0.75	3.00	3.75	1.88
CD8+ T Cells, donor3	11383-118B6	122.20	6.56	2.27	2.27	2.02	1.77
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	77.30	8.26	4.36	5.05	0.92	0.23
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	76.93	5.75	2.88	4.07	1.20	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	73.60	4.92	3.56	4.65	0.82	0.27
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	88.26	10.51	5.10	4.80	1.50	0.60
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	85.19	8.64	4.56	2.88	0.72	0.72
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	78.68	7.96	3.18	6.14	0.91	0.45
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	89.09	7.82	5.87	4.35	1.52	0.22
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	84.23	10.00	2.90	3.68	0.53	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	86.54	8.91	4.22	6.10	0.70	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	97.20	9.96	4.23	4.53	0.91	0.30
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	94.41	9.30	5.23	6.10	0.58	0.58
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	90.59	9.06	3.73	6.39	0.53	0.53
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	78.36	12.26	3.50	7.44	1.31	1.31
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	79.24	13.21	2.73	5.47	0.46	0.46
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	65.64	7.46	6.71	5.22	0.75	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	77.79	8.28	5.04	3.96	1.44	0.36
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	77.68	11.22	2.59	5.47	0.86	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	77.54	7.07	4.48	4.71	1.89	0.71
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	85.88	13.31	3.17	7.61	1.27	0.63
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	93.81	11.07	4.61	4.92	2.46	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	91.69	10.58	3.85	7.69	0.64	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	77.64	8.41	4.59	6.12	0.76	0.38
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	77.64	7.88	5.52	5.12	1.97	0.39
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	80.18	6.05	5.29	3.78	0.00	0.76
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	122.05	19.27	8.83	7.23	2.41	1.61
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	116.80	22.38	12.59	8.39	2.80	4.90
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	136.24	32.06	8.01	7.01	0.00	2.00
Cardiac Myocyte, donor1	11525-119I4	63.97	5.48	1.83	3.66	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	76.09	5.43	3.46	4.45	2.47	0.00
Cardiac Myocyte, donor3	11686-122I3	58.61	6.52	3.58	3.37	1.37	0.11
Chondrocyte - de diff, donor1	11261-116G1	72.80	5.55	3.47	1.39	1.73	1.73
Chondrocyte - de diff, donor2	11338-117F6	78.18	7.46	2.13	2.49	1.07	0.71
Chondrocyte - de diff, donor3	11410-118E6	71.91	8.19	3.41	2.16	5.23	0.80
Chondrocyte - re diff, donor2	11339-117F7	118.17	4.48	6.27	5.37	0.00	1.79
Chondrocyte - re diff, donor3	11411-118E7	81.29	7.68	3.24	3.24	3.24	1.62
Ciliary Epithelial Cells, donor1	11242-116D9	174.09	12.62	7.34	9.07	3.56	0.92
Ciliary Epithelial Cells, donor2	11323-117D9	148.35	12.61	7.48	5.13	2.99	0.00
Ciliary Epithelial Cells, donor3	11399-118D4	155.76	13.63	8.50	6.46	2.30	0.00
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	137.09	14.67	12.10	2.84	2.48	1.28
Corneal Epithelial Cells, donor1	11526-119I5	72.46	8.56	8.12	3.51	1.54	0.22
Corneal Epithelial Cells, donor2	11606-120I4	84.18	9.10	7.96	1.14	2.28	3.41
Corneal Epithelial Cells, donor3	11687-122I4	78.48	8.44	5.37	1.28	1.79	0.77
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	63.56	3.14	1.49	2.64	1.82	0.17
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	64.66	4.73	1.89	0.95	1.26	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	27.61	6.90	0.00	0.00	3.45	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	58.31	5.62	2.05	1.08	1.51	0.22
Dendritic Cells - plasmacytoid, donor1	11228-116C4	87.80	2.05	1.71	0.68	1.02	0.68
Dendritic Cells - plasmacytoid, donor2	11309-117C4	53.54	0.00	0.65	0.65	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	77.92	2.42	0.48	0.48	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	117.91	9.01	3.17	6.50	2.33	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	76.28	5.87	3.52	4.69	0.59	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	117.93	8.20	6.50	7.07	3.39	0.28
Endothelial Cells - Aortic, donor3	11412-118E8	129.75	12.58	7.86	7.86	1.57	0.00
Endothelial Cells - Artery, donor1	11264-116G4	89.59	12.51	5.53	3.49	0.87	0.87
Endothelial Cells - Artery, donor2	11341-117F9	102.58	9.41	6.12	4.00	4.47	0.00
Endothelial Cells - Artery, donor3	11413-118E9	130.43	10.87	5.43	8.59	1.23	0.18
Endothelial Cells - Lymphatic, donor1	11236-116D3	94.65	8.42	4.21	6.87	1.11	0.66
Endothelial Cells - Lymphatic, donor2	11317-117D3	86.11	12.78	3.65	3.04	0.61	0.61
Endothelial Cells - Lymphatic, donor3	11393-118C7	86.54	9.30	3.95	5.36	0.56	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	106.08	8.91	5.05	3.86	2.67	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	89.03	7.29	5.21	5.21	1.04	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	97.83	11.48	6.38	6.38	2.69	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	105.23	10.00	5.60	5.20	1.60	0.40
Endothelial Cells - Thoracic, donor2	11343-117G2	82.29	14.15	4.72	5.77	5.24	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	158.29	11.18	6.96	8.45	1.99	0.62
Endothelial Cells - Umbilical vein, donor2	11324-117E1	87.12	11.30	5.21	4.13	1.74	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	107.23	15.14	6.47	4.15	2.32	0.12
Endothelial Cells - Vein, donor1	11267-116G7	72.80	14.79	4.55	5.69	0.00	1.14
Endothelial Cells - Vein, donor2	11344-117G3	127.13	9.08	4.89	8.38	2.10	0.70
Endothelial Cells - Vein, donor3	11416-118F3	123.09	14.76	5.97	7.69	3.30	0.31
Eosinophils, donor1	12244-129H3	60.99	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	75.91	1.65	0.00	3.30	1.65	9.90
Eosinophils, donor3	12246-129H5	60.64	3.57	0.00	3.57	0.00	3.57
Esophageal Epithelial Cells, donor1	11507-119G4	57.66	5.62	3.42	1.71	1.22	1.22
Esophageal Epithelial Cells, donor2	11587-120G3	54.08	20.80	0.00	0.00	0.00	2.08
Esophageal Epithelial Cells, donor3	11668-122G3	48.81	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	51.72	5.34	4.11	4.11	4.11	1.64
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	35.26	5.47	3.07	2.74	1.20	0.33
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	60.45	6.83	3.90	2.28	1.30	0.43
Fibroblast - Aortic Adventitial, donor1	11245-116E3	86.96	6.06	3.40	3.03	0.85	0.49
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	61.28	8.32	2.73	4.50	0.55	0.41
Fibroblast - Aortic Adventitial, donor2	11326-117E3	70.03	6.43	4.11	3.59	2.11	0.42
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	70.88	5.27	4.74	2.90	0.26	0.00
Fibroblast - Aortic Adventitial, donor3	11401-118D6	83.71	12.62	4.32	2.99	1.66	0.00
Fibroblast - Cardiac, donor1	11268-116G8	87.10	13.61	4.08	6.35	0.45	0.00
Fibroblast - Cardiac, donor2	11345-117G4	87.16	7.58	5.31	3.79	3.03	0.00
Fibroblast - Cardiac, donor3	11417-118F4	56.30	7.25	3.15	3.15	2.37	0.32
Fibroblast - Cardiac, donor4	11452-119A3	101.54	6.97	3.64	4.85	0.61	0.30
Fibroblast - Cardiac, donor5	11456-119A7	76.27	9.26	3.68	3.30	1.40	0.38
Fibroblast - Cardiac, donor6	11460-119B2	84.74	9.55	4.24	5.00	1.21	0.15
Fibroblast - Choroid Plexus, donor1	11492-119E7	132.92	10.99	5.76	4.02	0.80	0.40
Fibroblast - Choroid Plexus, donor2	11572-120E6	97.93	5.61	3.02	2.59	2.59	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	104.00	14.65	7.32	4.39	4.39	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	140.69	23.06	10.15	3.00	1.15	1.38
Fibroblast - Conjunctival, donor3	11692-122I9	118.21	6.44	3.56	3.22	0.34	0.17
Fibroblast - Dermal, donor1	11269-116G9	59.87	7.98	4.23	1.88	1.17	0.70
Fibroblast - Dermal, donor2	11346-117G5	96.22	7.08	4.72	3.30	0.47	0.47
Fibroblast - Dermal, donor3	11418-118F5	74.71	6.17	2.66	2.78	2.06	0.12
Fibroblast - Dermal, donor4	11450-119A1	88.06	9.72	6.78	1.24	1.81	0.11
Fibroblast - Dermal, donor5	11454-119A5	96.12	13.78	6.45	1.57	1.40	0.52
Fibroblast - Dermal, donor6	11458-119A9	103.46	11.04	5.85	1.95	1.79	0.49
Fibroblast - Gingival, donor1	11237-116D4	103.07	7.50	3.33	2.29	2.92	0.21
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	113.45	8.38	7.07	2.36	0.79	0.26
Fibroblast - Gingival, donor2	11318-117D4	108.33	9.75	4.09	2.77	3.82	0.26
Fibroblast - Gingival, donor3	11394-118C8	97.17	11.70	4.35	2.03	1.74	0.29
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	78.96	7.27	3.12	6.23	1.04	1.04
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	106.60	7.75	3.17	3.70	2.29	0.18
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	120.98	13.10	5.92	2.65	2.96	0.78
Fibroblast - Gingival, donor6 (control)	11922-125H5	102.64	7.03	4.33	2.30	2.98	0.27
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	139.74	14.82	16.23	3.88	0.00	0.71
Fibroblast - Gingival, donor7 (control)	11924-125H7	100.18	6.00	3.95	3.36	1.32	0.00
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	112.36	6.00	4.77	1.77	3.14	1.09
Fibroblast - Gingival, donor8 (control)	11926-125H9	111.34	8.12	4.28	3.73	1.21	0.66
Fibroblast - Gingival, donor9 (control)	11927-125I1	136.61	8.66	5.43	3.37	2.93	1.03
Fibroblast - Lung, donor1	11270-116H1	66.61	4.08	2.72	1.36	1.36	0.00
Fibroblast - Lung, donor2	11347-117G6	91.02	7.46	7.46	2.98	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	109.11	9.50	2.74	3.59	6.12	0.21
Fibroblast - Lymphatic, donor1	11506-119G3	161.61	17.49	5.00	4.17	0.00	0.83
Fibroblast - Lymphatic, donor2	11586-120G2	89.51	5.59	4.20	1.40	2.80	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	71.93	4.48	3.92	1.12	1.12	0.00
Fibroblast - Mammary, donor1	11540-120B1	163.20	14.21	9.34	2.84	1.22	1.62
Fibroblast - Mammary, donor2	11620-122A9	87.87	11.98	3.99	3.99	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	41.69	0.00	5.96	11.91	5.96	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	97.57	10.47	4.27	0.78	2.13	0.58
Fibroblast - Periodontal Ligament, donor2	11319-117D5	145.46	16.38	7.58	2.28	1.67	0.61
Fibroblast - Periodontal Ligament, donor3	11395-118C9	103.42	12.24	6.12	2.75	0.31	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	82.81	9.16	3.05	0.38	0.38	0.76
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	86.94	7.02	3.24	2.43	1.62	1.08
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	95.68	9.39	3.94	2.78	1.04	0.35
Fibroblast - Pulmonary Artery, donor1	11250-116E8	66.21	5.97	2.87	4.86	2.98	0.11
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	172.71	15.04	11.58	5.89	0.61	2.03
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	128.30	8.69	6.01	3.34	1.34	0.67
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	73.14	4.74	3.16	2.37	2.77	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	96.64	10.32	6.55	3.97	0.60	0.20
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	61.63	6.04	2.31	1.42	0.18	0.71
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	66.61	4.14	2.56	3.74	1.18	0.59
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	81.23	9.03	3.31	1.50	0.90	0.30
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	81.29	6.37	2.48	2.27	1.08	0.54
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	79.72	6.83	4.30	1.27	0.76	0.25
Fibroblast - skin normal, donor1	11553-120C5	74.82	6.23	2.46	0.98	0.98	1.31
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	82.41	9.42	3.61	2.21	1.00	1.00
Fibroblast - skin normal, donor2	11561-120D4	79.67	6.13	3.21	2.51	1.11	1.11
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	99.44	9.97	4.84	3.93	0.60	0.60
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	83.59	5.72	2.82	3.56	1.82	0.50
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	89.75	5.13	3.42	4.10	1.54	0.68
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	82.76	6.57	3.28	2.96	0.33	0.33
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	83.73	4.47	3.62	2.13	2.56	0.43
Fibroblast - skin walker warburg, donor1	11554-120C6	97.83	7.93	4.89	4.39	1.86	0.00
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	63.04	3.61	1.57	3.14	3.29	1.10
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	44.32	0.00	0.00	0.00	132.96	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	68.85	5.23	2.61	1.74	1.74	1.74
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	75.41	7.97	5.03	5.55	1.04	0.87
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	67.40	10.41	3.64	2.60	1.04	0.52
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	77.42	12.01	7.92	3.58	0.51	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	160.77	23.73	23.73	9.19	12.25	2.30
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	137.82	18.50	14.68	8.29	12.12	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	133.22	27.10	17.97	7.42	21.39	1.43
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	144.22	36.12	33.64	10.20	14.34	1.38
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	121.01	18.72	24.20	8.45	8.45	0.91
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	138.69	28.33	23.38	6.14	14.27	0.79
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	136.93	33.31	28.02	11.10	12.16	1.32
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	127.85	26.74	21.85	9.46	6.85	2.28
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	96.85	15.04	14.15	4.42	7.08	0.88
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	146.83	28.69	23.32	5.51	3.53	0.71
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	131.39	23.64	17.24	4.68	2.09	1.23
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	134.58	20.68	19.88	2.95	2.95	0.54
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	119.19	19.95	13.26	3.35	1.24	0.25
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	124.03	18.96	11.35	2.77	1.52	0.28
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	96.98	18.91	10.37	3.05	1.83	0.61
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	111.81	16.20	9.58	4.34	2.97	0.23
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	108.62	17.19	13.83	3.61	1.25	0.37
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	101.86	19.89	8.96	1.31	1.97	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	109.92	14.48	9.16	4.73	2.95	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	126.05	19.71	10.81	4.29	2.38	0.79
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	122.21	18.77	10.72	4.02	3.57	1.12
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	151.23	14.72	10.28	4.84	3.43	0.40
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	146.23	18.83	14.59	5.26	2.54	0.51
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	136.47	16.05	10.11	6.83	1.86	0.44
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	148.18	20.60	9.05	6.24	2.29	0.73
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	127.40	11.78	8.37	4.10	1.02	0.34
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	129.91	17.93	9.96	2.99	1.55	0.55
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	119.22	13.56	6.57	6.24	2.16	0.50
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	97.60	15.93	8.98	5.10	1.02	0.82
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	128.12	17.33	7.01	4.13	4.13	0.62
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	139.85	21.33	8.53	4.84	1.73	0.46
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	122.07	17.01	7.67	3.50	2.67	0.17
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	122.12	17.85	5.07	3.97	2.20	0.44
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	137.75	19.56	8.12	4.30	2.46	0.61
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	128.86	16.37	10.37	6.00	3.08	0.97
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	124.76	15.39	7.38	4.17	4.49	0.64
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	115.88	16.68	11.56	3.22	1.71	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	100.60	12.81	6.64	3.01	2.21	0.16
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	102.17	10.95	6.69	3.65	2.13	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	121.47	16.62	10.56	3.35	2.51	0.10
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	99.24	16.03	7.90	3.95	3.51	0.44
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	118.67	15.99	7.01	2.24	4.49	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	127.68	12.13	6.48	6.30	1.20	0.19
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	101.35	14.97	8.29	7.22	4.01	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	118.27	11.48	5.51	4.28	2.91	0.15
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	105.18	12.05	4.53	4.15	2.33	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	108.70	14.91	4.07	3.80	0.81	0.27
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	141.77	14.93	6.82	5.35	3.69	0.37
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	139.48	15.79	6.58	7.68	2.19	0.44
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	143.80	18.84	6.94	9.92	0.99	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	127.82	10.16	4.62	4.88	3.17	0.13
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	107.94	8.07	2.82	4.64	3.43	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	230.01	21.10	8.39	13.22	2.03	0.25
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	118.64	18.91	18.11	3.18	2.19	2.19
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	138.21	26.66	22.65	3.70	2.00	1.23
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	182.69	37.85	32.53	6.55	1.43	1.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	138.32	22.22	17.84	5.95	4.07	0.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	123.48	17.24	14.69	4.80	2.54	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	124.06	28.13	21.68	2.77	3.23	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	138.59	17.32	14.85	9.90	2.47	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	158.59	30.17	17.02	8.90	5.03	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	154.03	28.88	30.48	8.02	4.81	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	161.71	36.52	6.96	12.17	5.22	1.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	142.23	19.20	14.65	4.88	3.58	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	165.54	25.53	18.12	4.94	2.88	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	233.26	36.65	26.66	13.33	0.00	3.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	124.16	18.46	15.38	3.64	4.47	0.56
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	140.54	20.59	16.67	4.58	8.82	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	166.93	27.68	14.26	5.03	2.52	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	161.58	18.13	11.45	3.18	1.27	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	143.34	11.21	12.91	5.43	5.09	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	137.82	8.35	6.26	2.09	4.18	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	159.21	21.19	13.17	4.58	4.01	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	107.74	17.76	10.36	1.78	4.14	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	144.00	22.02	3.39	5.08	1.69	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	148.70	24.85	11.18	3.31	1.24	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	171.45	20.25	14.73	6.21	4.14	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	131.71	10.54	0.00	0.00	5.27	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	122.63	16.15	8.07	3.08	4.61	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	113.11	14.02	7.17	1.63	4.56	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	98.99	18.73	10.03	2.01	2.68	0.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	164.12	11.17	10.40	3.85	2.70	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	224.57	28.41	18.14	9.93	3.77	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	136.66	9.94	19.88	4.97	2.48	2.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	129.29	22.18	14.63	2.83	4.72	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	120.10	20.52	3.62	3.02	1.81	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	136.83	16.28	13.23	3.05	4.58	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	126.43	17.95	10.77	4.79	3.59	0.80
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	111.50	16.28	9.87	1.48	5.92	1.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	146.37	20.07	7.08	3.54	2.36	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	117.27	17.50	9.92	2.33	1.75	0.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	128.59	23.26	10.09	3.07	2.63	0.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	141.56	16.11	10.17	9.32	5.09	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	138.48	16.12	7.16	1.79	4.78	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	114.03	10.19	5.82	2.43	1.46	0.97
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	63.91	7.99	1.14	2.28	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	85.66	6.24	0.83	1.66	3.74	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	123.69	3.37	4.50	7.87	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	69.46	4.12	4.76	1.90	2.85	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	57.23	4.18	2.09	1.67	2.51	0.42
Hep-2 cells mock treated, biol_rep1	11898-125E8	81.81	9.75	5.22	2.67	2.55	0.23
Hep-2 cells mock treated, biol_rep2	11899-125E9	84.91	10.80	8.27	2.03	1.35	0.17
Hep-2 cells mock treated, biol_rep3	11900-125F1	83.95	10.69	6.37	2.05	1.82	1.14
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	73.35	11.26	5.36	1.86	2.95	0.55
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	76.72	10.75	6.23	2.36	1.72	0.64
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	68.46	10.98	6.89	2.15	1.08	0.65
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	59.03	6.97	3.99	3.36	3.24	0.25
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	56.61	8.75	4.63	1.20	1.20	0.34
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	41.33	6.73	5.77	2.24	0.96	0.96
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	102.41	15.11	7.28	5.04	2.80	0.56
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	116.85	15.15	10.82	6.06	4.76	0.87
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	58.16	5.29	2.64	2.64	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	113.58	12.35	7.76	6.35	1.06	0.35
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	100.99	10.90	4.36	2.91	1.45	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	60.67	6.64	5.25	3.85	5.42	0.17
Hepatocyte, donor1	11523-119I2	79.90	4.84	1.21	1.21	2.42	1.21
Hepatocyte, donor2	11603-120I1	67.87	4.31	3.23	12.93	1.08	1.08
Hepatocyte, donor3	11684-122I1	65.04	6.14	3.68	0.61	1.23	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	75.71	16.32	1.96	0.65	1.96	0.65
Intestinal epithelial cells (polarized), donor1	11246-116E4	135.11	10.66	4.89	4.72	2.62	1.05
Iris Pigment Epithelial Cells, donor1	11530-119I9	68.05	6.45	3.98	1.51	1.51	0.27
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	95.52	9.55	0.00	6.37	3.18	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	53.40	20.03	20.03	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	81.25	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	63.68	11.08	4.15	4.15	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	50.05	10.01	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	59.34	0.00	11.87	0.00	23.74	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	58.95	12.81	7.69	2.56	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	54.85	4.57	9.14	4.57	0.00	4.57
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	79.59	6.50	4.87	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	63.36	10.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	54.46	18.15	14.52	3.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	75.44	5.29	5.29	6.62	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	57.65	4.43	5.54	3.33	2.22	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	89.05	5.24	5.24	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	76.21	7.56	8.19	2.52	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	74.24	6.19	7.73	1.55	1.55	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	73.17	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	112.41	9.69	8.40	4.52	0.00	0.65
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	101.43	20.93	4.83	4.83	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	191.17	11.95	23.90	0.00	0.00	11.95
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	97.79	9.78	7.33	4.07	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	93.20	6.30	5.04	2.94	0.00	0.42
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	57.49	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	118.95	8.84	11.25	3.21	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	71.09	5.54	5.54	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	105.57	0.00	45.24	15.08	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	60.42	8.50	2.83	1.89	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	63.49	9.07	6.35	0.91	1.81	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	103.20	14.74	44.23	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	93.62	10.76	6.46	4.30	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	86.39	5.08	12.70	2.54	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	16.43	0.00	16.43	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	90.55	10.20	11.48	1.91	0.00	1.28
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	89.31	9.11	3.65	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	79.02	0.00	31.61	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	87.83	9.28	7.14	0.71	0.00	0.71
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	96.23	3.32	3.32	0.00	0.00	3.32
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	83.39	20.85	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	76.55	8.33	4.01	1.54	0.31	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	79.02	8.78	3.51	3.51	0.00	1.76
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	69.15	6.29	3.14	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	81.36	10.43	9.74	1.39	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	99.59	11.07	4.43	4.43	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	84.29	9.73	3.24	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	111.61	13.08	4.36	1.74	0.00	0.87
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	78.74	6.75	6.75	2.25	0.00	2.25
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	69.69	10.45	10.45	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	82.14	18.14	6.40	1.07	0.00	1.07
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	63.73	6.93	5.54	2.77	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	82.64	0.00	2.85	2.85	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	92.04	8.28	1.84	2.76	0.92	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	75.63	18.15	3.03	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	43.46	6.21	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	77.19	6.34	3.17	2.11	1.06	0.00
Keratinocyte - epidermal, donor1	11272-116H3	79.64	8.49	6.77	4.90	0.90	0.08
Keratinocyte - epidermal, donor2	11349-117G8	61.49	11.71	3.51	2.34	0.00	1.17
Keratinocyte - epidermal, donor3	11421-118F8	69.00	7.67	3.60	1.04	1.42	0.47
Keratinocyte - oral, donor1	11251-116E9	102.62	11.47	7.27	1.93	3.29	1.36
Keratocytes, donor1	11527-119I6	108.65	14.10	6.88	0.00	1.38	0.00
Keratocytes, donor2	11607-120I5	101.95	7.03	2.34	3.52	2.34	2.34
Keratocytes, donor3	11688-122I5	66.20	8.69	3.56	1.98	0.79	0.40
Krukenberg tumor cell line:HSKTC	10687-109F3	50.55	8.79	2.20	2.20	6.59	0.00
Lens Epithelial Cells, donor1	11529-119I8	76.59	7.55	6.47	3.24	2.16	0.00
Lens Epithelial Cells, donor2	11609-120I7	113.60	13.84	7.27	6.69	4.38	0.92
Lens Epithelial Cells, donor3	11690-122I7	80.53	8.17	4.94	4.34	1.61	0.20
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	85.49	10.20	5.81	3.68	2.96	0.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	63.91	6.70	4.19	3.63	2.51	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	91.77	7.40	6.45	2.99	4.41	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	68.83	3.23	9.14	3.23	3.76	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	90.77	9.77	3.15	2.52	1.58	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	86.68	7.87	4.96	4.20	3.88	0.11
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	68.95	7.39	6.16	3.28	3.28	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	76.86	6.57	5.06	3.79	4.30	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	89.52	7.18	3.94	2.96	3.52	0.14
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	65.26	8.70	1.98	1.58	1.98	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	69.99	10.08	5.23	3.49	2.33	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	87.02	8.33	5.00	3.15	3.89	0.19
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	60.97	4.88	3.83	3.14	3.14	0.35
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	71.08	5.25	4.77	3.82	1.67	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	86.25	9.75	5.08	3.85	4.26	0.14
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	75.14	8.01	3.70	4.62	2.77	0.62
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	62.35	5.61	3.12	3.12	2.49	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	97.53	11.16	6.04	2.93	3.84	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	65.16	6.91	3.29	2.30	2.96	0.33
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	67.95	6.44	5.27	4.10	2.34	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	100.57	10.21	4.73	4.23	3.49	0.25
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	56.26	6.30	3.88	1.94	1.94	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	56.01	6.46	5.66	3.23	1.89	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	102.33	7.87	3.63	2.27	4.24	0.15
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	52.88	7.78	6.22	3.63	2.07	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	66.80	6.91	5.03	3.14	1.26	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	96.24	8.72	3.91	4.81	4.66	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	83.23	8.25	6.19	2.75	6.19	0.69
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	59.83	8.28	3.76	2.45	1.51	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	85.88	5.94	4.88	4.77	4.24	0.11
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	67.84	9.21	2.42	2.91	2.91	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	65.17	6.62	3.97	2.65	1.98	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	92.05	8.55	4.71	4.58	3.22	0.12
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	87.00	11.11	4.81	2.59	2.59	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	57.08	6.18	4.20	3.46	2.22	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	85.66	7.84	6.60	3.16	3.16	0.14
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	70.12	6.43	4.18	4.82	2.25	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	80.65	6.39	7.00	3.65	2.13	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	87.76	9.24	4.90	4.20	3.22	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	82.85	9.60	4.62	4.62	4.27	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	56.72	5.82	6.30	2.42	2.42	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	90.25	7.94	5.76	4.98	4.05	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	71.98	6.80	4.66	2.86	3.22	1.43
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	75.14	8.17	7.19	4.25	1.31	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	74.16	6.83	4.71	1.88	4.71	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	84.89	9.78	6.19	4.21	3.96	0.12
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	60.96	4.87	3.07	1.28	0.77	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	83.84	6.56	4.18	2.69	1.49	0.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	70.25	11.33	4.53	9.06	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	113.54	9.21	3.84	2.30	0.00	0.77
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	103.91	11.88	5.20	2.97	1.48	1.48
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	147.25	12.69	9.31	2.54	4.23	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	121.67	11.96	6.33	3.52	2.11	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	98.07	5.60	6.54	1.87	0.00	0.93
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	123.15	9.79	9.79	1.03	1.55	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	88.02	16.65	7.14	7.14	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	118.07	10.40	5.88	4.98	0.68	0.23
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	117.79	8.72	6.11	2.04	2.62	0.87
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	100.39	11.70	6.75	1.80	4.95	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	154.32	14.50	9.89	5.69	1.08	0.68
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	123.25	16.95	5.65	4.11	4.11	0.51
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	112.21	14.47	7.06	2.47	3.18	0.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	97.28	11.33	4.66	2.67	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	135.50	19.36	9.17	4.08	4.08	1.02
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	118.73	16.01	7.74	2.67	2.93	0.80
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	114.31	13.42	8.31	3.59	4.16	1.13
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	116.58	14.11	6.14	3.07	1.84	0.61
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	129.65	18.75	7.34	2.45	1.63	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	117.24	13.33	7.08	3.54	6.46	0.83
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	116.31	12.33	8.97	3.08	5.61	0.56
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	127.76	13.39	13.39	1.03	2.06	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	117.57	13.93	9.58	4.94	4.94	0.58
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	103.13	15.25	5.68	3.59	4.19	0.30
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	110.10	17.15	8.85	1.66	3.32	0.55
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	158.36	19.44	6.36	2.83	3.53	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	136.45	16.60	7.74	4.43	4.79	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	103.61	14.97	5.76	2.30	5.76	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	138.92	17.65	6.14	4.22	4.99	0.77
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	148.33	13.59	7.93	4.53	3.96	0.57
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	100.92	13.95	15.59	2.46	2.46	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	128.79	15.82	11.30	4.97	5.87	0.45
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	127.83	17.24	8.62	5.75	4.31	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	118.01	11.95	3.73	2.99	5.23	0.75
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	146.41	19.69	7.43	3.34	2.97	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	92.61	12.92	7.75	1.72	3.02	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	111.32	22.26	10.28	4.28	1.71	1.71
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	130.27	17.66	7.00	4.66	3.00	0.67
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	116.44	17.50	7.84	1.81	3.02	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	103.09	14.93	10.66	3.55	1.42	2.84
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	127.86	17.87	8.59	1.37	4.47	0.34
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	113.79	17.71	8.05	2.15	4.83	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	122.55	16.83	4.71	2.69	1.35	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	134.46	18.15	7.04	2.22	4.44	0.74
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	76.75	5.81	2.33	3.49	1.16	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	104.72	20.10	3.17	4.23	2.12	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	131.65	14.81	11.20	2.00	3.20	0.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	130.84	18.17	10.18	2.18	2.18	0.73
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	144.87	17.63	13.03	1.53	1.53	0.77
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	143.05	21.70	5.92	5.43	5.92	1.48
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	153.37	26.35	12.23	3.76	7.53	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	161.41	19.11	11.56	3.52	3.52	0.50
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	140.59	15.77	9.46	4.51	2.70	0.90
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	168.67	15.49	8.61	3.44	1.72	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	147.85	26.72	11.58	4.45	3.56	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	150.54	18.38	9.38	3.52	2.35	1.56
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	129.97	17.15	5.94	4.62	2.64	0.66
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	126.62	18.68	9.34	3.63	4.15	1.04
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	155.77	21.44	9.19	7.00	5.69	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	125.80	13.98	12.86	4.47	2.80	1.12
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	147.51	21.20	10.16	4.86	2.65	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	155.06	17.36	7.71	5.79	3.86	0.77
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	135.20	16.71	8.10	4.56	4.05	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	152.84	22.11	7.69	1.92	3.36	0.48
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	153.06	17.09	7.55	2.39	3.98	0.40
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	132.46	18.23	7.90	3.65	1.82	1.22
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	103.06	10.38	9.68	2.77	3.46	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	150.48	23.18	7.60	2.66	1.90	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	137.88	24.79	9.30	4.65	5.16	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	121.54	17.53	6.05	3.02	0.60	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	141.97	17.11	9.82	4.75	3.17	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	142.87	22.92	9.60	5.33	3.20	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	149.99	16.67	12.07	2.87	0.57	0.57
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	147.59	18.00	7.20	3.09	4.63	0.51
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	159.86	15.56	11.32	3.54	3.54	1.41
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	154.92	16.46	8.51	3.40	0.57	0.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	162.67	20.80	9.98	4.16	2.91	1.66
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	129.98	14.09	11.75	6.26	2.35	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	121.51	16.28	5.01	1.67	1.25	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	131.03	19.98	10.22	1.86	1.86	1.39
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	97.68	16.73	6.69	0.67	2.01	0.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	114.41	16.04	8.55	0.53	0.53	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	120.82	17.78	6.06	0.81	2.02	0.40
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	125.73	19.27	9.18	2.75	3.67	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	122.70	19.56	9.78	2.67	0.89	0.89
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	140.76	20.52	10.26	0.57	1.14	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	119.64	14.57	19.94	2.30	2.30	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	118.74	12.59	7.66	1.64	0.55	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	130.52	22.72	11.14	3.12	3.56	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	143.24	17.94	8.58	4.68	1.30	0.78
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	145.88	16.58	11.27	0.66	1.33	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	143.42	22.86	16.63	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	59.94	4.33	2.96	0.68	1.14	0.23
Macrophage - monocyte derived, donor2	11313-117C8	45.51	3.67	2.75	0.55	0.55	0.55
Macrophage - monocyte derived, donor3	11389-118C3	71.96	5.37	3.67	1.18	1.70	0.66
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	39.83	4.25	2.12	2.66	1.59	0.00
Mallassez-derived cells, donor2	11929-125I3	54.19	5.39	3.80	3.96	0.95	0.63
Mallassez-derived cells, donor3	11930-125I4	51.56	5.00	3.89	3.61	0.83	0.42
Mammary Epithelial Cell, donor1	11273-116H4	71.44	8.97	4.38	1.49	1.69	0.50
Mammary Epithelial Cell, donor2	11350-117G9	63.41	8.11	8.11	0.87	0.87	1.16
Mammary Epithelial Cell, donor3	11422-118F9	91.04	6.98	2.74	4.74	0.50	0.50
Mast cell - stimulated, donor1	11487-119E2	69.15	2.71	2.03	6.10	0.68	0.68
Mast cell, donor1	11563-120D6	118.74	9.52	5.41	2.05	2.27	1.51
Mast cell, donor2	11565-120D8	154.83	9.21	8.02	4.16	2.97	0.59
Mast cell, donor3	11566-120D9	170.64	13.06	7.43	2.48	2.70	0.68
Mast cell, donor4	11567-120E1	151.94	13.47	4.96	5.50	1.42	1.60
Mast cell, expanded and stimulated, donor5	11940-126A5	104.24	5.10	2.88	2.33	1.33	0.33
Mast cell, expanded and stimulated, donor8	11942-126A7	96.89	3.50	0.58	2.33	1.17	0.58
Mast cell, expanded, donor5	11939-126A4	113.57	6.88	4.36	1.61	1.26	0.69
Mast cell, expanded, donor8	11941-126A6	132.05	4.35	3.85	3.51	1.17	1.17
Melanocyte - dark, donor1	11502-119F8	75.72	8.26	4.48	4.38	1.79	0.20
Melanocyte - dark, donor2	11582-120F7	75.45	4.85	3.11	5.88	3.81	0.00
Melanocyte - dark, donor3	11663-122F7	106.92	10.36	6.59	5.80	3.04	0.51
Melanocyte - light, donor1	11274-116H5	73.11	5.17	3.53	3.06	1.18	0.24
Melanocyte - light, donor2	11351-117H1	109.19	12.28	4.09	6.82	0.68	0.00
Melanocyte - light, donor3	11423-118G1	86.72	5.20	2.60	5.20	0.87	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	82.68	9.89	5.00	2.92	1.77	0.10
Melanocyte, donor2 (MC+2)	12739-135I3	90.90	10.76	5.11	5.11	3.77	0.54
Melanocyte, donor3 (MC+3)	12837-137B2	105.00	8.04	4.02	4.55	3.75	0.54
Meningeal Cells, donor1	11493-119E8	174.43	17.37	11.66	2.85	0.50	0.62
Meningeal Cells, donor2	11573-120E7	116.20	12.76	8.80	3.08	0.44	0.00
Meningeal Cells, donor3	11654-122E7	124.94	7.74	7.25	3.67	2.36	0.57
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	88.11	7.41	6.27	3.71	3.99	0.29
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	72.25	5.43	2.52	3.62	0.81	0.30
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	61.77	7.88	1.31	3.94	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	49.71	5.23	3.92	1.31	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	46.64	5.74	2.87	0.72	2.15	0.72
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	76.24	6.78	3.81	5.08	2.33	0.42
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	89.97	9.05	3.02	2.01	1.51	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	109.88	12.97	9.01	3.08	1.54	0.66
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	101.55	12.42	6.58	5.11	1.46	0.73
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	112.74	11.05	7.57	3.07	2.46	0.20
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	68.84	5.54	4.29	1.25	1.66	0.28
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	90.70	9.66	3.72	2.60	2.23	0.74
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	86.31	6.45	4.08	3.29	2.11	0.00
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	80.71	8.61	4.45	3.86	2.08	0.59
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	67.73	2.34	4.67	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	100.54	7.68	5.76	1.92	3.20	0.64
Mesenchymal stem cells - adipose, donor0	11217-116B2	57.42	3.54	2.84	2.84	1.77	1.06
Mesenchymal stem cells - hepatic, donor0	11218-116B3	69.74	5.63	3.13	1.88	4.07	0.63
Mesenchymal stem cells - umbilical, donor0	11214-116A8	64.59	5.08	2.90	0.73	2.18	0.00
Mesothelial Cells, donor1	11247-116E5	67.62	5.57	3.71	3.98	2.39	0.53
Mesothelial Cells, donor2	12156-128G5	66.06	3.00	2.50	4.00	0.50	0.00
Mesothelial Cells, donor3	11402-118D7	84.62	6.94	3.97	4.99	3.25	0.29
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	44.56	2.70	0.00	1.35	6.75	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	53.69	4.68	2.96	1.72	0.74	0.74
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	65.37	7.95	0.59	2.06	1.18	0.29
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	34.57	0.00	0.00	6.91	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	43.39	1.86	2.48	0.93	1.24	0.31
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	57.46	3.73	3.11	1.04	1.45	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	30.11	6.95	0.00	0.00	2.32	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	54.81	7.26	2.00	0.50	2.00	0.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	63.77	3.72	5.12	0.47	0.93	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	38.93	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	57.10	5.89	1.02	2.44	1.42	1.02
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	62.96	5.15	1.19	1.58	0.00	0.40
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	17.10	8.55	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	32.74	3.54	1.77	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	52.43	3.80	1.52	1.52	1.90	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	25.00	2.63	1.32	1.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	37.14	3.40	1.27	0.21	0.85	0.21
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	19.34	3.68	0.92	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	37.85	4.77	1.49	0.30	0.60	0.30
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	20.12	3.35	1.68	1.68	1.68	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	67.90	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	32.37	3.26	0.75	1.25	1.76	0.25
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	43.73	3.80	2.14	0.48	1.90	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	13.27	1.11	0.55	1.11	0.55	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	21.87	2.53	0.92	0.23	0.92	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	41.86	2.94	0.84	1.47	1.05	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	29.96	1.43	0.82	0.82	0.00	0.41
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	26.82	3.43	1.29	0.64	0.43	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	30.90	4.00	1.56	0.89	0.22	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	30.96	10.32	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	17.74	1.31	1.31	0.00	0.44	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	19.26	2.03	1.01	0.00	0.51	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	18.23	1.66	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	24.46	3.26	0.54	0.00	0.54	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	22.94	2.06	1.47	0.29	0.29	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	14.17	2.18	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	20.18	3.36	0.48	0.00	0.48	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	30.82	1.60	1.20	0.40	0.00	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	13.71	4.11	0.00	0.00	1.37	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	27.53	3.00	1.00	1.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	8.15	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	25.84	1.31	0.44	1.31	0.44	1.31
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	12.14	1.10	0.00	1.10	3.31	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	16.65	1.92	0.64	0.64	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	25.04	1.98	0.74	0.74	0.99	0.25
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	17.40	0.70	0.70	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	19.89	4.42	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	34.87	4.10	0.68	0.00	0.34	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	19.69	0.88	0.88	0.44	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	15.27	1.78	0.71	0.36	1.07	0.36
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	29.46	1.96	1.96	0.28	0.28	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	27.43	0.83	1.25	0.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	16.32	2.91	1.17	0.58	0.58	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	32.58	4.52	0.30	0.60	0.60	0.30
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	32.97	5.01	0.83	0.42	0.83	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	43.31	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	33.25	0.92	0.92	1.85	0.92	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	31.30	0.57	3.98	1.14	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	34.55	2.76	2.21	0.69	0.14	0.14
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	25.66	2.59	1.55	0.52	0.52	0.26
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	35.61	3.43	2.14	0.43	0.43	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	22.87	2.54	0.00	0.64	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	29.36	2.94	1.60	0.80	0.53	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	50.59	6.29	2.39	0.90	0.90	0.30
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	34.75	3.39	2.26	0.57	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	28.98	2.87	1.91	0.32	0.32	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	38.26	5.75	3.32	0.44	0.66	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	31.47	0.38	1.52	0.38	0.38	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	37.22	3.98	0.57	0.28	0.28	0.28
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	38.84	6.64	3.20	0.74	0.49	0.49
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	32.58	4.56	2.61	0.00	1.30	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	42.34	5.59	2.06	0.88	1.18	0.29
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	57.09	6.92	2.31	0.58	0.58	0.58
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	56.46	4.95	1.65	0.82	1.65	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	41.99	2.68	1.49	0.60	0.00	0.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	26.37	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	14.26	1.78	1.78	1.78	1.78	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	51.91	4.60	0.99	0.33	1.31	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	31.56	1.05	2.10	0.00	0.00	2.10
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	53.97	3.95	2.17	0.99	2.77	0.79
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	54.02	8.38	1.86	0.00	3.73	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	50.32	4.13	3.38	0.75	2.25	1.13
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	40.48	2.40	1.07	0.80	0.27	0.27
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	39.47	3.05	1.92	0.68	0.45	0.23
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	39.78	2.95	2.21	2.21	0.74	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	51.30	4.76	2.93	0.00	2.56	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	46.67	6.22	0.00	0.00	1.56	1.56
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	6.95	0.53	0.53	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	7.73	3.86	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	41.41	5.05	1.01	0.00	2.02	1.01
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	20.66	1.69	0.84	0.00	0.42	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	4.09	0.00	1.36	2.72	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	2.54	1.91	0.00	0.00	0.00	0.64
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	3.24	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	12.08	1.51	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	57.10	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	48.94	9.79	0.00	3.26	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	23.76	9.50	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	75.29	0.00	0.00	12.55	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	75.83	9.05	5.60	5.60	1.08	0.22
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	81.00	8.88	6.27	1.05	1.05	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	75.43	13.35	11.35	2.00	2.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	60.52	9.60	9.18	0.83	2.50	0.42
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	68.45	3.61	4.56	2.28	2.47	0.19
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	92.56	3.19	7.98	4.79	3.19	1.60
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	62.55	14.28	5.44	2.04	0.68	0.68
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	86.37	5.51	0.00	0.00	20.21	3.68
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	72.82	13.81	13.39	0.84	2.93	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	62.99	9.07	7.44	1.63	3.95	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	97.55	11.35	5.67	2.97	0.81	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	87.25	7.99	5.05	4.20	1.89	0.21
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	77.94	0.00	0.00	0.00	22.27	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	108.70	7.94	5.96	0.99	0.99	0.99
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	51.97	5.14	1.08	1.62	3.52	0.27
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	60.52	10.20	4.99	1.13	1.59	0.23
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	80.67	11.59	6.21	2.61	0.98	0.16
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	86.57	9.66	5.47	2.19	1.64	0.18
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	84.87	12.20	7.96	2.12	1.06	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	91.25	9.60	8.40	1.20	2.40	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	65.64	2.95	1.97	0.66	2.63	0.33
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	61.63	10.25	6.50	1.46	0.81	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	91.90	10.05	3.35	3.17	2.65	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	94.23	14.77	4.92	2.81	0.70	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	66.20	9.19	2.76	0.92	2.30	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	101.22	16.39	4.82	2.57	2.25	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	62.42	4.14	4.48	2.41	7.93	0.34
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	136.54	2.53	0.00	22.76	12.64	2.53
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	74.19	8.69	5.12	3.12	1.11	0.67
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	71.13	6.35	2.54	2.54	2.54	0.42
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	51.27	5.93	2.85	1.19	2.14	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	84.99	18.89	10.73	2.15	1.29	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	90.28	0.00	9.03	0.00	144.44	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	75.31	8.33	3.67	1.33	0.67	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	73.94	8.57	5.86	4.96	0.00	0.45
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	67.46	9.92	5.95	1.59	1.98	0.79
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	70.58	11.14	2.79	0.93	1.86	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	68.11	8.32	3.41	1.14	1.51	0.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	74.63	18.25	7.82	0.98	1.30	0.33
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	72.78	6.97	3.05	1.31	1.74	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	84.58	11.31	3.17	3.62	2.26	0.90
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	62.62	9.70	2.65	2.65	0.88	0.88
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	104.38	9.31	6.65	1.33	0.66	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	80.86	10.91	5.95	1.98	0.99	1.49
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	68.53	14.93	7.27	1.15	2.30	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	75.91	7.86	2.42	1.51	0.60	0.91
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	87.30	9.73	5.08	3.76	1.55	0.66
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	94.19	10.84	4.74	0.00	0.00	0.68
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	91.97	0.00	0.00	0.00	25.55	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	85.97	11.58	5.49	1.22	3.05	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	52.88	8.18	5.35	1.26	5.04	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	73.54	11.20	6.05	0.61	3.33	0.91
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	79.11	14.24	4.75	1.58	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	78.22	4.53	2.27	4.53	3.40	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	45.52	10.12	5.06	25.29	25.29	0.00
Myoblast, donor1	11241-116D8	62.49	7.70	3.35	2.48	1.24	0.62
Myoblast, donor2	11322-117D8	104.72	10.74	5.95	3.45	2.11	0.00
Myoblast, donor3	11398-118D3	91.82	7.57	4.37	4.37	2.19	0.50
NK T cell leukemia cell line:KHYG-1	10777-110G3	134.70	10.22	2.19	3.36	5.55	1.02
Natural Killer Cells, donor1	11230-116C6	95.02	2.77	0.92	4.31	0.92	4.31
Natural Killer Cells, donor2	11311-117C6	102.23	5.43	1.21	3.02	2.41	1.51
Natural Killer Cells, donor3	11387-118C1	104.17	3.68	2.76	3.31	1.66	0.74
Neural stem cells, donor1	11275-116H6	170.58	9.07	12.70	21.05	1.81	1.45
Neural stem cells, donor2	11352-117H2	229.15	44.29	25.03	7.70	1.93	0.00
Neurons, donor1	11494-119E9	188.89	42.10	18.21	7.97	3.41	0.00
Neurons, donor2	11574-120E8	239.98	30.16	22.02	8.59	4.40	0.22
Neurons, donor3	11655-122E8	158.68	29.60	18.91	9.87	7.40	0.00
Neutrophils, donor1	11233-116C9	74.24	4.64	2.78	1.86	0.93	0.00
Neutrophils, donor2	11314-117C9	69.57	5.80	2.90	0.00	0.00	2.90
Neutrophils, donor3	11390-118C4	89.79	6.11	3.67	3.05	0.00	3.05
Nucleus Pulposus Cell, donor1	11252-116F1	143.20	7.01	5.94	3.44	1.54	0.00
Nucleus Pulposus Cell, donor2	11409-118E5	126.33	8.47	3.58	2.93	1.95	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	74.81	6.82	3.41	0.80	2.01	0.00
Olfactory epithelial cells, donor1	11933-125I7	73.37	7.02	4.96	2.62	3.85	0.28
Olfactory epithelial cells, donor2	11934-125I8	83.08	7.96	4.78	3.04	5.50	0.00
Olfactory epithelial cells, donor3	11935-125I9	75.14	7.04	5.11	1.70	5.68	0.23
Olfactory epithelial cells, donor4	11936-126A1	85.42	6.82	4.58	1.27	2.24	0.19
Oligodendrocyte - precursors, donor1	11496-119F2	73.42	9.03	3.61	2.41	1.81	0.60
Osteoblast - differentiated, donor1	11276-116H7	75.72	3.62	2.55	4.04	0.64	1.06
Osteoblast - differentiated, donor2	11353-117H3	62.87	2.29	0.00	0.00	2.29	0.00
Osteoblast - differentiated, donor3	11425-118G3	46.55	3.72	5.59	0.00	2.48	0.00
Osteoblast, donor1	11277-116H8	145.80	10.36	6.45	11.14	4.10	1.17
Osteoblast, donor2	11354-117H4	102.54	14.05	10.53	2.81	4.92	0.70
Osteoblast, donor3	11426-118G4	137.92	14.04	4.98	5.69	1.78	1.07
Pancreatic stromal cells, donor1	11249-116E7	80.36	5.14	3.03	1.60	3.37	0.76
Pericytes, donor1	11491-119E6	121.39	11.24	8.01	2.34	0.89	0.22
Pericytes, donor2	11571-120E5	151.89	14.26	6.11	3.17	1.58	0.45
Pericytes, donor3	11652-122E5	89.92	10.17	5.90	2.85	2.85	0.00
Perineurial Cells, donor1	11499-119F5	79.00	7.46	5.31	0.68	1.24	0.34
Perineurial Cells, donor2	11579-120F4	85.02	6.72	3.31	6.07	1.84	0.18
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	111.24	4.14	4.46	1.27	0.32	0.64
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	81.29	5.14	1.71	1.47	0.49	1.96
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	90.85	4.14	1.04	1.81	0.39	1.16
Placental Epithelial Cells, donor1	11278-116H9	65.05	7.41	3.11	1.20	2.87	0.48
Placental Epithelial Cells, donor2	11355-117H5	63.21	12.20	6.65	1.11	1.11	0.00
Placental Epithelial Cells, donor3	11427-118G5	96.99	6.87	3.53	2.55	2.36	0.20
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	59.49	3.48	4.75	2.85	0.63	0.32
Preadipocyte - breast, donor1	11467-119B9	69.97	5.25	4.50	4.50	2.44	0.75
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	52.73	6.00	2.48	3.52	1.04	0.00
Preadipocyte - breast, donor2	11328-117E5	76.78	6.53	1.80	4.28	2.70	0.00
Preadipocyte - omental, donor1	11468-119C1	79.60	6.93	3.94	4.58	1.07	0.43
Preadipocyte - omental, donor2	11329-117E6	77.26	7.42	3.49	5.24	0.87	0.00
Preadipocyte - omental, donor3	11403-118D8	73.06	9.17	3.44	4.01	2.86	0.14
Preadipocyte - perirenal, donor1	11469-119C2	58.07	10.83	4.92	0.98	3.94	0.98
Preadipocyte - subcutaneous, donor1	11279-116I1	113.63	6.45	7.06	9.83	0.31	0.92
Preadipocyte - subcutaneous, donor2	11356-117H6	104.83	7.26	2.66	2.12	3.54	0.53
Preadipocyte - subcutaneous, donor3	11428-118G6	93.49	7.66	2.72	4.77	1.53	0.34
Preadipocyte - visceral, donor1	11280-116I2	99.11	6.61	5.68	2.51	2.89	0.65
Preadipocyte - visceral, donor2	11357-117H7	98.48	7.82	5.52	4.14	3.68	0.00
Preadipocyte - visceral, donor3	11429-118G7	77.11	5.33	3.24	2.72	2.09	0.10
Prostate Epithelial Cells (polarized), donor1	11253-116F2	103.03	11.46	5.28	3.62	3.47	0.60
Prostate Epithelial Cells, donor2	11331-117E8	62.83	11.10	4.87	2.98	1.76	0.14
Prostate Epithelial Cells, donor3	11404-118D9	40.60	11.08	3.37	0.80	1.10	0.43
Prostate Stromal Cells, donor1	11254-116F3	81.67	6.83	4.10	2.96	3.99	0.80
Prostate Stromal Cells, donor2	11332-117E9	105.43	9.14	4.48	3.77	4.84	0.00
Prostate Stromal Cells, donor3	11405-118E1	88.84	7.72	4.69	3.44	2.50	0.52
Renal Cortical Epithelial Cells, donor1	11516-119H4	97.45	12.04	7.66	2.19	2.92	0.73
Renal Cortical Epithelial Cells, donor2	11596-120H3	70.35	9.77	6.10	1.52	1.80	0.28
Renal Epithelial Cells, donor1	11517-119H5	118.69	11.16	11.16	4.06	0.51	0.51
Renal Epithelial Cells, donor2	11597-120H4	141.55	19.92	10.67	4.27	3.56	0.00
Renal Epithelial Cells, donor3	11678-122H4	98.14	12.39	8.05	2.96	2.96	0.64
Renal Glomerular Endothelial Cells, donor1	11514-119H2	99.40	10.89	6.13	3.40	0.68	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	93.53	11.45	6.74	2.16	1.62	0.27
Renal Glomerular Endothelial Cells, donor3	11675-122H1	83.70	9.10	5.11	3.55	1.11	0.44
Renal Glomerular Endothelial Cells, donor4	11783-124B1	91.83	5.99	4.66	2.00	0.00	0.67
Renal Mesangial Cells, donor1	11518-119H6	149.00	17.83	10.56	4.40	2.42	0.00
Renal Mesangial Cells, donor2	11598-120H5	176.81	18.18	11.29	3.13	3.13	0.63
Renal Mesangial Cells, donor3	11679-122H5	126.78	14.15	7.21	4.16	5.27	0.28
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	88.58	10.47	8.05	2.42	1.07	0.81
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	67.47	10.12	6.33	1.27	0.84	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	145.21	13.69	7.91	4.24	3.86	0.39
Retinal Pigment Epithelial Cells, donor0	11215-116A9	94.64	11.67	6.22	2.07	6.48	0.26
Retinal Pigment Epithelial Cells, donor1	11528-119I7	154.34	16.77	15.06	4.55	3.98	0.28
Retinal Pigment Epithelial Cells, donor2	11608-120I6	118.35	8.23	12.35	3.09	4.12	1.03
Retinal Pigment Epithelial Cells, donor3	11689-122I6	84.05	13.80	8.28	2.26	2.01	0.75
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	81.79	8.02	5.08	2.67	2.27	0.67
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	90.23	8.04	0.89	3.57	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	83.11	7.15	3.85	2.20	1.65	1.10
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	74.83	4.06	2.90	1.74	0.00	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	85.95	8.06	3.51	2.47	1.30	0.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	111.62	11.12	5.76	2.68	1.49	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	127.71	13.27	7.36	6.02	1.56	0.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	116.72	11.29	5.46	2.98	1.49	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	111.07	10.96	4.89	3.26	1.75	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	132.21	17.33	7.17	4.39	0.23	0.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	86.66	9.86	5.07	1.92	0.27	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	114.36	8.62	4.69	3.33	0.61	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	117.19	10.75	6.27	3.23	1.25	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	105.15	10.76	5.59	2.01	0.29	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	115.04	12.99	5.90	2.68	2.15	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	122.58	11.28	5.09	4.65	1.77	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	78.38	8.79	4.59	3.82	0.38	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	105.74	12.20	3.54	3.07	1.58	0.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	133.04	13.34	6.76	6.01	0.38	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	91.30	11.28	3.85	3.58	0.66	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	116.32	11.19	6.04	4.48	1.56	0.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	126.03	13.94	5.54	5.16	0.76	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	94.09	11.21	5.77	2.67	0.21	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	107.92	10.93	3.08	4.48	1.68	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	121.34	10.25	5.30	3.76	1.20	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	88.79	9.30	3.46	1.82	0.36	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	111.96	9.69	5.27	3.19	0.98	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	129.62	13.16	4.30	5.78	1.88	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	105.20	11.09	9.67	4.25	0.47	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	132.54	10.91	5.75	5.36	2.18	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	118.79	12.86	7.95	6.08	1.17	1.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	83.56	11.40	6.22	4.35	0.21	0.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	121.67	11.50	7.30	5.09	1.77	0.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	114.05	12.74	8.98	5.01	1.25	0.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	99.32	13.32	5.65	3.90	0.54	0.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	97.07	7.32	5.45	6.13	1.87	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	110.28	10.60	3.47	3.86	1.74	0.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	93.19	10.49	4.64	3.44	1.20	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	95.33	8.64	4.39	4.25	1.10	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	122.47	10.84	5.09	4.60	1.81	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	82.15	7.84	3.58	2.39	0.17	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	123.99	9.91	4.88	3.26	1.33	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	105.82	11.73	3.73	7.20	1.33	0.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	94.57	11.20	6.08	2.49	0.41	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	98.57	6.67	5.95	3.10	2.14	0.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	130.60	12.29	6.85	4.23	0.40	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	87.02	10.08	3.86	3.96	0.75	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	116.34	14.67	5.94	3.84	1.05	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	96.71	12.09	3.63	3.32	0.30	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	92.77	10.53	3.43	2.45	0.73	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	189.22	18.92	8.59	8.44	1.31	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	116.82	16.43	4.87	4.26	2.43	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	98.56	7.53	2.71	2.11	0.60	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	142.72	16.06	5.88	3.17	3.39	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	133.30	16.77	7.19	3.00	2.40	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	88.91	8.62	3.31	3.07	0.59	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	139.38	18.57	10.46	4.70	0.64	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	122.60	18.03	3.61	2.40	2.40	0.00
Schwann Cells, donor1	11498-119F4	125.82	11.47	8.84	2.07	1.69	0.94
Schwann Cells, donor2	11578-120F3	81.66	3.40	6.80	0.00	3.40	0.00
Schwann Cells, donor3	11659-122F3	100.78	10.08	5.70	2.63	3.72	0.00
Sebocyte, donor1	11220-116B5	132.56	14.24	12.05	4.93	1.10	0.00
Sebocyte, donor2	11301-117B5	95.13	8.27	6.43	2.76	5.97	0.00
Sebocyte, donor3	11378-118B1	101.82	11.34	5.77	1.44	2.89	0.41
Sertoli Cells, donor1	11255-116F4	81.17	13.25	6.63	1.66	3.31	1.66
Sertoli Cells, donor2	11333-117F1	84.73	8.47	8.47	2.82	0.00	2.82
Skeletal Muscle Cells, donor1	11281-116I3	111.20	11.53	5.63	2.55	2.73	0.44
Skeletal Muscle Cells, donor2	11358-117H8	115.66	3.61	5.06	2.17	2.17	0.00
Skeletal Muscle Cells, donor3	11430-118G8	162.19	11.70	7.52	5.02	4.18	0.00
Skeletal Muscle Cells, donor4	11451-119A2	81.06	7.85	4.56	1.73	1.73	0.79
Skeletal Muscle Cells, donor5	11455-119A6	92.16	9.36	4.46	1.93	2.38	0.00
Skeletal Muscle Cells, donor6	11459-119B1	83.88	10.62	6.16	2.62	2.31	0.15
Skeletal Muscle Satellite Cells, donor1	11240-116D7	117.19	7.43	3.28	2.65	2.90	0.88
Skeletal Muscle Satellite Cells, donor2	11321-117D7	106.45	8.70	5.85	3.00	1.71	0.43
Skeletal Muscle Satellite Cells, donor3	11397-118D2	120.24	9.62	5.65	3.87	1.19	0.30
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	143.14	9.69	5.81	7.92	3.29	0.25
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	121.59	11.58	7.24	4.34	2.90	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	116.41	9.63	3.72	4.54	4.54	0.41
Skin - palm, donor1	10286-104F7	91.33	13.43	5.37	2.69	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	45.27	7.78	11.53	1.59	0.86	0.00
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	96.51	23.72	9.00	3.27	0.00	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	61.15	11.42	7.92	1.69	0.26	0.13
Small Airway Epithelial Cells, donor1	11256-116F5	44.20	6.67	5.28	2.78	0.83	0.83
Small Airway Epithelial Cells, donor2	11334-117F2	57.81	13.08	7.45	2.11	2.67	0.28
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	138.71	14.59	10.78	6.13	1.27	0.42
Small Airway Epithelial Cells, donor3	11406-118E2	65.51	14.69	6.07	0.82	1.57	0.45
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	58.32	8.64	2.78	3.39	0.00	0.62
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	51.36	6.23	2.89	1.56	0.67	0.44
Smooth Muscle Cells - Aortic, donor0	11210-116A4	94.64	8.23	3.53	7.05	0.59	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	54.14	4.20	3.54	1.77	0.88	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	91.36	9.45	8.27	5.91	0.00	0.39
Smooth Muscle Cells - Aortic, donor3	11432-118H1	103.52	7.73	3.86	6.95	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	102.08	5.00	0.00	4.00	7.01	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	73.73	4.79	2.66	4.52	2.00	0.53
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	58.52	6.43	3.55	2.88	2.22	0.89
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	55.95	5.89	2.05	3.20	0.13	0.51
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	66.75	5.86	3.91	2.93	0.98	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	67.63	8.56	4.13	2.36	1.18	0.89
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	61.64	7.40	2.99	2.85	0.71	0.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	88.82	9.92	6.67	2.60	1.63	0.16
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	62.10	5.18	4.87	0.30	0.61	0.30
Smooth Muscle Cells - Carotid, donor1	11285-116I7	95.47	6.06	4.29	5.56	0.76	0.25
Smooth Muscle Cells - Carotid, donor2	11362-117I3	73.45	12.24	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	53.88	3.81	2.86	3.34	1.43	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	61.50	4.72	2.06	1.47	1.03	0.15
Smooth Muscle Cells - Colonic, donor2	11320-117D6	80.50	6.67	4.74	2.15	1.51	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	84.07	8.29	3.15	2.83	1.05	0.10
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	108.89	9.74	6.96	6.34	3.09	0.31
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	88.39	6.47	8.62	7.55	4.31	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	80.09	8.37	5.08	5.08	1.49	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	99.01	7.85	6.15	3.76	1.02	1.02
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	89.44	6.75	3.14	2.20	1.57	0.31
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	83.83	9.86	6.54	3.32	1.51	0.50
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	67.13	5.23	4.78	3.87	3.64	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	73.06	5.43	3.62	2.42	1.81	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	93.78	5.56	4.50	2.91	1.32	0.79
Smooth Muscle Cells - Prostate, donor1	11257-116F6	73.64	7.46	5.33	1.73	1.07	0.53
Smooth Muscle Cells - Prostate, donor2	11335-117F3	95.92	9.77	5.13	4.38	1.75	0.00
Smooth Muscle Cells - Prostate, donor3	11465-119B7	63.92	2.03	1.78	2.28	0.51	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	116.55	6.03	3.92	5.73	1.06	0.30
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	87.02	9.00	2.25	2.25	3.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	68.49	9.05	10.34	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	130.68	10.70	5.58	6.51	2.33	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	67.15	11.11	4.04	3.03	6.56	1.01
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	83.99	11.91	5.95	4.39	1.25	0.31
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	59.29	7.96	3.24	2.36	0.88	0.29
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	103.97	8.25	5.91	3.17	2.42	1.00
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	86.42	7.94	3.74	2.34	0.47	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	79.30	6.04	3.02	6.04	1.73	0.58
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	94.59	8.16	4.08	5.35	2.80	0.25
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	75.78	7.90	2.63	3.76	2.44	0.94
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	76.02	6.29	4.89	1.68	2.10	0.00
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	61.00	7.04	2.93	1.93	1.93	0.00
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	42.38	6.19	1.43	0.48	0.48	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	74.13	5.87	4.65	6.12	0.49	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	62.09	5.52	1.99	4.64	1.77	0.22
Smooth Muscle Cells - Uterine, donor3	11466-119B8	48.86	3.80	2.93	1.46	1.76	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	75.80	3.69	2.33	1.55	0.58	0.19
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	40.73	2.91	2.91	1.59	0.26	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	70.30	1.12	1.86	1.12	1.49	0.37
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	65.40	5.75	5.39	0.72	1.44	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	55.64	5.68	4.54	3.97	0.85	0.28
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	56.32	3.54	5.12	0.39	1.58	0.79
Smooth muscle cells - airway, control, donor1	11966-126D4	49.52	3.56	1.52	1.78	0.76	0.51
Smooth muscle cells - airway, control, donor2	11967-126D5	53.11	7.19	3.99	0.40	1.20	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	57.27	3.34	2.09	1.25	1.67	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	54.09	0.92	2.75	2.75	0.46	0.46
Synoviocyte, donor1	11291-117A4	75.07	4.88	2.86	3.87	2.36	0.67
Synoviocyte, donor2	11368-117I9	63.19	5.03	2.85	1.68	3.52	0.84
Synoviocyte, donor3	11440-118H9	55.63	3.57	2.68	1.12	1.12	0.22
Trabecular Meshwork Cells, donor1	11532-120A2	190.81	16.08	14.65	3.93	1.43	1.07
Trabecular Meshwork Cells, donor2	11612-122A1	63.43	9.91	3.96	3.96	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	132.44	18.76	10.42	3.47	1.39	0.93
Tracheal Epithelial Cells, donor1	11292-117A5	68.53	8.32	4.59	2.44	3.08	1.15
Tracheal Epithelial Cells, donor2	11369-118A1	68.81	7.34	3.09	2.32	0.77	0.39
Tracheal Epithelial Cells, donor3	11441-118I1	60.13	9.16	2.29	0.00	0.00	0.57
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	83.53	9.84	4.31	2.09	1.11	0.98
Urethra, donor2	10319-105A4	124.09	23.38	10.79	1.80	0.00	0.00
Urothelial Cells, donor1	11520-119H8	77.04	12.22	5.84	3.72	1.86	0.00
Urothelial Cells, donor2	11600-120H7	66.09	7.21	3.20	1.20	2.80	0.40
Urothelial Cells, donor3	11681-122H7	68.30	7.11	4.35	1.60	1.60	1.38
Urothelial cells, donor0	11216-116B1	80.24	7.58	4.01	2.45	2.67	0.67
Whole blood (ribopure), donor090309, donation1	12179-129A1	95.21	4.45	3.56	0.00	0.00	4.45
Whole blood (ribopure), donor090309, donation2	12180-129A2	100.07	10.01	10.01	2.86	0.00	5.72
Whole blood (ribopure), donor090309, donation3	12181-129A3	95.83	6.85	3.42	2.05	1.37	2.05
Whole blood (ribopure), donor090325, donation1	12176-128I7	96.41	2.07	3.44	1.03	2.75	1.72
Whole blood (ribopure), donor090325, donation2	12177-128I8	92.38	5.23	5.23	1.16	0.00	3.49
Whole blood (ribopure), donor090612, donation1	12182-129A4	87.46	5.21	4.16	3.12	1.04	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	77.09	7.34	1.84	0.00	0.92	1.84
Whole blood (ribopure), donor090612, donation3	12184-129A6	78.51	5.48	2.74	1.83	1.83	1.83
Wilms' tumor cell line:G-401	10809-111A8	126.57	16.28	10.36	2.71	3.58	0.37
Wilms' tumor cell line:HFWT	10597-108E3	73.92	7.92	8.80	4.40	2.64	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	74.86	7.54	9.22	1.96	0.28	0.28
achilles tendon, donor2	10292-104G4	37.20	6.20	0.00	2.07	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	54.56	5.35	2.29	1.53	0.76	0.25
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	159.04	11.38	7.66	1.86	3.71	1.16
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	178.42	18.16	6.65	5.34	3.21	0.71
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	141.50	12.25	5.71	1.09	2.72	0.27
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	57.90	5.06	3.09	0.84	1.12	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	102.15	4.86	3.17	0.85	0.85	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	54.44	2.99	1.91	0.82	0.54	1.91
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	49.35	3.53	2.20	0.00	1.32	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	60.85	4.08	0.82	0.82	0.41	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	220.17	22.13	6.21	3.49	6.99	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	66.98	5.89	4.23	0.37	0.74	0.92
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	113.11	0.00	3.90	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	142.68	9.06	5.11	2.09	1.16	0.23
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	152.75	11.91	5.95	1.81	3.37	1.55
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	149.34	11.40	9.64	0.29	0.88	0.88
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	103.18	8.83	3.72	2.79	1.39	0.46
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	78.14	6.17	2.06	0.41	0.00	0.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	69.06	15.04	10.44	0.61	0.92	0.31
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	61.87	5.55	3.84	0.43	1.28	0.85
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	67.63	5.16	6.07	1.21	0.30	1.21
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	66.92	6.50	5.54	1.20	0.48	0.48
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	90.21	8.69	3.79	0.67	1.11	2.23
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	153.77	12.01	9.67	2.00	1.00	1.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	46.46	1.86	3.72	3.72	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	211.52	10.90	8.72	2.18	2.18	0.87
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	80.60	20.62	15.00	5.62	5.62	1.87
adenocarcinoma cell line:IM95m	10796-110I4	38.39	3.53	0.94	0.94	0.24	1.18
adipose tissue, adult, pool1	10010-101C1	83.92	7.29	3.72	2.02	0.93	0.47
adipose, donor1	10184-103D4	107.31	7.62	6.45	9.38	17.59	1.76
adipose, donor2	10185-103D5	83.54	30.41	35.69	0.00	9.33	0.81
adipose, donor3	10186-103D6	96.66	19.88	13.61	5.72	5.99	0.82
adipose, donor4	10187-103D7	89.28	13.00	9.53	6.93	7.80	0.87
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	71.81	11.52	6.94	3.47	2.05	0.47
adrenal gland, adult, pool1	10081-102A9	69.12	10.91	10.91	3.64	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	62.03	5.74	3.34	0.53	0.67	1.07
alveolar cell carcinoma cell line:SW 1573	10708-109H6	134.70	10.36	4.64	2.50	4.29	1.43
amniotic membrane cells, donor1	12235-129G3	58.19	4.41	1.62	1.39	0.70	2.09
amniotic membrane cells, donor2	12236-129G4	85.88	4.73	3.38	1.35	2.37	1.35
amniotic membrane cells, donor3	12237-129G5	54.80	8.84	4.12	0.59	0.88	4.12
amygdala - adult, donor10196	10167-103B5	154.15	28.46	27.27	1.19	0.00	1.19
amygdala, adult, donor10252	10151-102I7	150.66	30.01	18.05	5.27	5.47	1.82
amygdala, newborn, donor10223	10360-105E9	123.30	14.20	16.14	4.84	2.58	0.32
anaplastic carcinoma cell line:8305C	10428-106D5	95.50	12.99	4.84	1.91	0.38	0.00
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	60.45	6.40	1.99	2.21	1.10	0.66
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	177.37	17.70	6.01	4.01	3.34	0.67
aorta, adult, pool1	10052-101G7	89.83	10.00	4.31	1.37	1.37	0.39
appendix, adult	10189-103D9	111.39	10.87	8.93	3.10	1.16	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	140.33	14.45	8.25	2.75	1.38	2.06
artery, adult	10190-103E1	138.59	16.30	9.51	0.00	2.72	0.00
astrocytoma cell line:TM-31	10425-106D2	207.59	25.50	10.58	11.59	2.61	1.16
b cell line:RPMI1788	10427-106D4	87.73	9.67	4.46	0.74	1.64	0.45
basal cell carcinoma cell line:TE 354.T	10702-109G9	62.43	6.94	3.33	1.66	2.50	1.11
bile duct carcinoma cell line:HuCCT1	10432-106D9	71.84	9.72	4.96	2.18	0.69	0.89
bile duct carcinoma cell line:TFK-1	10496-107C1	44.69	5.69	1.00	1.00	1.67	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	72.70	8.39	3.36	0.56	1.68	1.12
bladder, adult, pool1	10011-101C2	66.16	6.19	4.02	0.76	1.20	0.54
blood, adult, pool1	10053-101G8	50.94	13.29	2.21	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	57.38	4.28	2.57	0.86	1.71	0.86
bone marrow, adult	10192-103E3	77.60	4.72	2.70	3.37	0.67	0.00
brain, adult, donor1	10084-102B3	175.29	22.55	27.68	3.08	4.10	2.05
brain, adult, pool1	10012-101C3	170.04	25.61	20.38	3.45	2.90	2.56
brain, fetal, pool1	10085-102B4	288.51	40.07	40.07	0.00	10.69	0.00
breast carcinoma cell line:MCF7	10482-107A5	110.67	5.29	4.29	3.30	2.31	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	134.68	10.61	4.99	1.37	1.12	0.62
breast, adult, donor1	10080-102A8	65.66	12.00	8.21	1.26	0.63	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	58.69	5.97	3.81	2.79	1.78	0.00
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	118.12	14.22	2.78	2.47	4.64	0.31
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	123.40	9.21	5.53	0.92	2.30	0.23
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	77.95	6.78	2.66	3.15	2.18	0.24
carcinoid cell line:NCI-H1770	10703-109H1	94.50	18.34	9.87	1.41	3.29	0.47
carcinoid cell line:NCI-H727	10735-110B6	124.15	11.70	5.80	7.66	0.44	0.44
carcinoid cell line:SK-PN-DW	10719-109I8	54.19	8.24	5.07	0.63	3.49	0.63
carcinosarcoma cell line:JHUCS-1	10642-109A3	208.68	24.22	13.58	6.12	1.86	0.27
caudate nucleus - adult, donor10196	10177-103C6	122.04	18.42	17.27	1.15	1.15	2.30
caudate nucleus, adult, donor10252	10164-103B2	168.16	28.28	19.41	2.84	4.18	1.51
caudate nucleus, adult, donor10258	10379-105H1	204.03	22.92	22.16	0.00	3.06	0.76
caudate nucleus, newborn, donor10223	10354-105E3	135.87	10.25	13.18	6.96	0.73	0.37
cerebellum - adult, donor10196	10173-103C2	233.06	37.87	46.61	2.91	0.00	2.91
cerebellum, adult, donor10252	10166-103B4	222.26	58.29	38.22	2.78	3.84	5.55
cerebellum, adult, pool1	10083-102B2	171.44	30.01	25.87	3.10	5.86	3.45
cerebellum, newborn, donor10223	10357-105E6	126.20	14.95	39.85	4.98	3.32	1.66
cerebral meninges, adult	10188-103D8	111.70	12.61	11.09	3.03	3.53	2.77
cerebrospinal fluid, donor2	10294-104G6	59.20	8.04	5.12	1.46	0.73	0.00
cervical cancer cell line:D98-AH2	10552-107I3	53.20	9.92	4.46	0.43	1.44	0.86
cervical cancer cell line:ME-180	10553-107I4	85.51	16.57	7.95	2.32	2.32	0.50
cervix, adult, pool1	10013-101C4	117.06	10.81	5.67	2.41	1.68	0.63
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	133.76	11.43	4.46	4.88	2.09	0.70
chondrosarcoma cell line:SW 1353	10700-109G7	41.80	7.84	3.92	1.31	1.31	0.00
choriocarcinoma cell line:BeWo	10423-106C9	70.09	9.94	7.33	1.99	1.37	0.50
choriocarcinoma cell line:SCH	10785-110H2	50.64	9.86	4.81	0.74	1.72	0.00
choriocarcinoma cell line:T3M-3	10618-108G6	50.76	14.23	8.06	0.47	0.47	0.47
chorionic membrane cells, donor1	12238-129G6	49.86	2.85	2.28	0.00	0.85	0.57
chorionic membrane cells, donor2	12239-129G7	98.44	11.73	5.17	4.57	1.89	0.30
chorionic membrane cells, donor3	12240-129G8	53.30	3.30	1.65	1.10	1.65	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	70.69	5.05	1.01	3.03	2.02	2.02
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	47.06	3.84	1.54	0.77	2.31	0.96
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	43.93	5.70	2.53	1.69	0.42	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	59.58	7.96	7.70	1.03	0.77	0.51
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	87.32	7.50	6.05	1.21	0.00	0.48
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	67.39	6.72	5.50	0.81	0.41	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	102.76	8.83	6.18	2.65	2.65	0.59
chronic myelogenous leukemia cell line:KU812	10409-106B4	139.96	15.12	14.07	1.82	2.35	0.52
clear cell carcinoma cell line:JHOC-5	10638-108I8	86.40	8.46	5.71	0.69	1.60	0.23
clear cell carcinoma cell line:TEN	10636-108I6	31.93	2.43	1.04	1.21	1.21	0.35
colon carcinoma cell line:CACO-2	10513-107D9	140.39	8.79	7.50	3.84	5.86	0.37
colon carcinoma cell line:COLO-320	10420-106C6	161.53	16.34	10.26	3.42	2.28	0.00
colon, adult, donor1	10082-102B1	110.67	14.28	4.76	1.19	1.19	1.19
colon, adult, pool1	10014-101C5	82.60	6.35	2.94	2.12	1.18	1.41
colon, fetal, donor1	10070-101I7	67.98	8.03	4.33	1.24	1.24	0.00
common myeloid progenitor CMP, donor1	12130-128D6	348.35	22.92	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	100.15	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	153.40	16.57	8.92	15.72	0.42	0.85
cord blood derived cell line:COBL-a 24h infection	10453-106G3	109.12	6.49	4.38	8.90	1.21	0.60
cord blood derived cell line:COBL-a untreated	10449-106F8	135.37	6.77	4.37	10.15	2.54	1.41
corpus callosum, adult, pool1	10042-101F6	185.63	21.67	14.93	7.63	1.33	1.99
cruciate ligament, donor2	10295-104G7	61.60	4.86	3.24	2.43	1.62	0.00
diaphragm, fetal, donor1	10069-101I6	98.72	19.26	9.63	2.41	1.61	0.00
diencephalon, adult	10193-103E4	86.40	12.96	10.80	4.56	1.44	0.96
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	120.32	10.33	3.67	1.61	2.76	0.46
ductal cell carcinoma cell line:KLM-1	10438-106E6	119.76	13.08	8.46	6.67	2.82	3.59
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	70.53	9.87	4.81	1.44	1.69	0.72
ductus deferens, adult	10196-103E7	118.11	10.47	7.97	3.99	3.49	0.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	72.01	7.20	7.20	1.44	4.32	2.88
duodenum, fetal, donor1, tech_rep2	10071-101I8	114.03	11.77	6.62	3.68	1.47	2.21
dura mater, adult, donor1	10041-101F5	158.07	7.85	4.38	3.96	0.74	0.83
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	98.60	37.75	23.98	11.55	3.11	0.89
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	144.44	27.51	18.48	5.02	4.59	0.14
embryonic pancreas cell line:1B2C6	10604-108F1	33.30	8.02	1.85	0.00	1.23	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	54.79	4.24	3.03	0.61	0.91	0.30
embryonic pancreas cell line:1C3IKEI	10606-108F3	60.51	8.95	5.87	0.93	0.93	0.31
embryonic pancreas cell line:2C6	10603-108E9	39.40	3.94	1.31	1.31	1.31	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	99.55	7.04	5.36	3.69	2.35	0.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	117.80	13.23	7.25	1.09	3.26	2.17
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	67.86	7.88	6.27	0.80	0.64	0.48
epidermoid carcinoma cell line:A431	10426-106D3	42.02	4.34	2.89	1.33	0.56	0.56
epidermoid carcinoma cell line:Ca Ski	10431-106D8	70.39	10.12	4.07	1.43	0.88	0.99
epididymis, adult	10197-103E8	140.45	11.51	4.81	4.19	1.88	1.05
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	83.56	11.35	5.68	1.95	1.77	0.00
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	79.83	3.54	1.57	1.97	0.39	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	101.69	16.64	6.55	2.75	3.28	0.79
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	97.93	19.09	7.28	3.05	2.56	0.98
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	104.41	20.84	6.27	2.69	2.69	0.45
esophagus, adult, pool1	10015-101C6	59.14	4.67	3.50	0.74	1.70	0.42
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	207.14	12.15	5.39	6.26	1.88	0.63
eye - muscle inferior rectus, donor1	10272-104E2	108.66	24.15	7.24	2.41	4.83	0.00
eye - muscle lateral, donor2	10298-104H1	90.48	6.31	14.73	4.21	0.00	0.00
eye - muscle medial, donor2	10299-104H2	71.43	10.42	7.44	1.49	4.46	0.00
eye - muscle superior, donor2	10297-104G9	94.01	11.46	5.73	0.00	5.73	0.00
eye - vitreous humor, donor1	10268-104D7	68.50	5.83	4.37	2.91	2.91	0.00
eye, fetal, donor1	10054-101G9	117.46	19.32	7.63	1.78	2.29	2.29
fibrosarcoma cell line:HT-1080	10758-110E2	74.24	5.77	5.39	2.05	1.92	0.51
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	85.47	15.67	7.36	1.66	3.32	0.00
frontal lobe, adult, pool1	10040-101F4	225.65	31.81	27.02	5.25	3.38	3.94
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	105.09	13.51	6.61	5.10	3.90	0.90
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	108.99	7.31	5.30	2.47	0.82	0.09
gall bladder, adult	10198-103E9	90.78	8.93	3.62	4.83	1.45	0.72
gamma delta positive T cells, donor1	11937-126A2	83.21	4.83	1.07	2.15	1.61	0.54
gamma delta positive T cells, donor2	11938-126A3	71.34	3.36	2.24	1.12	1.87	1.87
gastric adenocarcinoma cell line:MKN1	10614-108G2	124.62	14.79	10.56	3.80	3.59	1.90
gastric adenocarcinoma cell line:MKN45	10612-108F9	91.29	9.28	5.42	1.74	0.97	0.58
gastric cancer cell line:AZ521	10549-107H9	160.35	21.64	10.49	9.51	1.97	0.49
gastric cancer cell line:GSS	10560-108A2	94.27	6.41	5.49	0.00	0.92	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	247.88	31.07	10.97	7.77	2.74	0.23
giant cell carcinoma cell line:LU65	10487-107B1	19.96	2.98	1.84	0.23	0.46	0.57
giant cell carcinoma cell line:Lu99B	10433-106E1	90.97	6.44	5.18	0.98	1.54	0.00
glassy cell carcinoma cell line:HOKUG	10688-109F4	81.81	14.97	4.99	3.24	2.74	0.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	144.50	10.34	8.23	4.64	1.79	0.95
glioblastoma cell line:A172, tech_rep2	10444-106F3	119.65	10.95	4.77	5.20	1.26	0.28
glioblastoma cell line:T98G	10485-107A8	166.77	6.62	2.65	5.52	4.08	1.32
glioma cell line:GI-1	10413-106B8	107.19	7.91	4.69	3.51	0.88	0.29
globus pallidus - adult, donor10196	10175-103C4	76.54	17.49	12.39	2.19	1.46	0.73
globus pallidus, adult, donor10252	10161-103A8	133.28	29.29	10.50	5.86	5.13	1.22
globus pallidus, adult, donor10258	10367-105F7	83.52	12.32	12.32	2.74	1.37	1.37
globus pallidus, newborn, donor10223	10364-105F4	100.19	11.72	11.19	5.33	1.60	1.60
granulocyte macrophage progenitor, donor1	12131-128D7	315.68	4.89	9.79	19.58	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	65.57	0.00	10.93	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	62.72	15.68	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	86.40	9.92	3.20	5.12	1.60	0.00
hIPS +CCl2, biol_rep1	14383-156B9	83.10	17.45	18.82	1.84	0.46	0.00
hIPS +CCl2, biol_rep2	14384-156C1	90.08	16.00	17.38	3.20	0.00	1.37
hIPS +CCl2, biol_rep3	14385-156C2	68.27	23.83	25.12	3.22	0.00	0.64
hIPS, biol_rep1	14380-156B6	53.18	11.50	28.75	1.44	1.44	0.00
hIPS, biol_rep2	14381-156B7	68.59	19.20	15.09	2.74	0.00	0.69
hIPS, biol_rep3	14382-156B8	89.38	22.07	29.79	3.31	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	123.85	16.67	8.62	2.87	5.17	0.29
heart - mitral valve, adult	10205-103F7	106.73	6.58	8.07	2.99	1.49	0.60
heart - pulmonic valve, adult	10206-103F8	136.49	12.03	5.23	3.14	1.31	0.52
heart - tricuspid valve, adult	10207-103F9	91.59	13.32	2.50	1.67	1.67	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	96.11	12.65	6.73	3.26	1.63	0.00
heart, adult, diseased, donor1	10051-101G6	114.97	14.90	6.39	2.13	1.70	1.28
heart, adult, pool1	10016-101C7	88.54	6.67	4.37	1.84	4.37	0.23
heart, fetal, pool1	10046-101G1	165.21	20.74	8.01	4.00	1.75	0.21
hepatic mesenchymal tumor cell line:LI90	10778-110G4	58.31	9.26	3.39	4.01	0.93	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	53.51	5.95	5.95	4.76	2.38	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	147.29	21.77	7.29	3.65	3.43	0.77
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	144.31	20.88	9.10	2.91	2.18	0.49
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	150.17	21.83	8.79	3.74	2.43	0.61
hepatoma cell line:Li-7	10484-107A7	93.87	10.79	4.00	3.11	1.89	0.00
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	75.07	9.75	5.13	0.90	1.41	0.50
hippocampus - adult, donor10196	10169-103B7	135.32	24.60	18.93	4.73	3.79	0.00
hippocampus, adult, donor10252	10153-102I9	132.05	23.27	13.67	3.67	5.71	1.63
hippocampus, adult, donor10258	10374-105G5	128.97	30.37	36.85	1.00	0.00	1.99
hippocampus, newborn, donor10223	10363-105F3	169.89	19.39	19.39	2.82	1.76	1.76
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	157.47	14.04	14.65	6.10	11.60	1.22
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	151.00	28.86	27.10	4.71	8.05	1.18
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	161.22	22.60	20.31	7.62	4.32	1.52
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	143.79	28.19	28.76	10.15	5.07	0.56
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	167.84	40.80	38.47	12.39	9.30	1.29
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	177.66	27.33	27.71	7.97	4.56	0.38
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	144.23	19.85	16.35	11.68	4.67	2.92
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	162.22	35.98	30.38	12.93	7.11	1.51
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	153.90	21.27	20.85	14.18	8.34	0.42
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	138.29	16.81	15.15	16.34	6.39	1.89
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	179.36	30.54	20.73	17.36	8.68	2.09
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	167.65	20.87	21.55	18.18	6.06	2.02
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	127.69	21.75	11.58	4.07	3.91	0.94
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	110.05	28.00	17.69	2.46	2.46	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	106.48	6.98	9.60	0.87	6.11	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	200.46	49.06	43.72	11.45	4.96	1.72
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	185.33	37.50	45.79	6.98	3.49	0.44
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	121.94	21.49	16.99	8.50	4.00	1.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	131.12	35.61	33.72	3.20	4.52	1.70
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	127.78	36.38	32.74	1.82	3.64	1.36
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	113.08	18.79	31.64	5.01	5.01	0.63
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	145.50	20.41	18.62	3.92	4.74	1.47
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	134.41	21.48	17.71	4.06	2.32	1.45
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	139.30	14.65	18.83	4.78	4.18	1.79
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	154.45	20.69	21.06	4.62	11.08	0.55
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	135.51	29.67	21.68	3.71	9.41	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	143.73	11.43	10.21	6.94	11.43	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	158.44	20.42	30.63	4.93	5.63	1.41
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	174.21	31.36	32.31	5.70	6.97	1.27
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	161.90	20.88	25.72	7.57	5.75	1.82
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	133.93	25.34	27.41	6.72	5.17	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	141.47	32.54	27.23	5.98	3.32	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	109.28	14.11	16.93	6.67	3.08	1.54
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	136.00	17.13	16.62	6.65	4.60	1.02
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	153.72	31.05	23.47	1.51	3.03	2.27
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	116.95	11.09	10.42	4.70	5.71	0.67
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	155.77	28.26	23.91	6.28	7.25	0.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	127.90	12.48	18.72	7.13	4.01	1.78
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	128.29	19.51	19.02	4.88	9.27	0.49
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	193.76	36.98	45.84	9.78	7.33	1.53
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	224.47	13.01	26.03	26.03	39.04	22.77
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	165.47	17.87	23.50	9.93	8.27	1.65
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	145.03	35.03	36.12	7.66	4.38	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	120.87	24.97	25.33	7.96	5.43	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	106.76	14.23	22.78	6.05	5.34	2.49
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	126.50	20.29	15.51	4.77	3.58	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	148.43	18.69	14.36	9.48	4.33	2.03
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	111.53	10.51	10.24	9.70	5.93	1.62
immature langerhans cells, donor1	11904-125F5	67.07	2.18	1.21	3.63	0.24	0.73
immature langerhans cells, donor2	11905-125F6	104.56	3.17	0.00	5.54	0.00	2.38
insula, adult, pool1	10039-101F3	283.33	42.02	32.93	6.06	3.03	2.65
keratoacanthoma cell line:HKA-1	10791-110H8	87.14	12.68	5.85	1.63	1.63	0.98
kidney, adult, pool1	10017-101C8	91.42	9.61	6.61	2.30	2.00	0.80
kidney, fetal, pool1	10045-101F9	182.00	19.45	12.24	3.96	1.06	1.06
large cell lung carcinoma cell line:IA-LM	10509-107D5	169.43	21.02	14.34	5.25	3.41	0.71
large cell lung carcinoma cell line:NCI-H460	10839-111E2	80.87	6.77	3.73	1.66	1.52	0.28
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	60.00	12.66	5.87	1.65	1.83	0.37
left atrium, adult, donor1	10079-102A7	67.56	7.63	5.45	1.09	2.18	0.54
left ventricle, adult, donor1	10078-102A6	81.92	7.58	5.56	2.02	2.02	0.00
leiomyoblastoma cell line:G-402	10721-110A1	58.01	4.38	2.19	3.56	1.64	0.00
leiomyoma cell line:10964C	10569-108B2	82.99	9.70	7.18	2.16	4.67	0.36
leiomyoma cell line:15242A	10570-108B3	66.85	9.24	7.07	7.07	4.35	0.00
leiomyoma cell line:15425	10571-108B4	73.09	9.47	6.31	2.19	3.16	0.24
leiomyosarcoma cell line:Hs 5.T	10722-110A2	69.84	0.00	0.00	12.70	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	101.42	12.55	10.46	6.27	1.05	1.05
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	92.91	11.57	5.90	2.60	1.53	0.12
liposarcoma cell line:KMLS-1	10782-110G8	112.47	11.40	5.15	3.75	1.09	0.00
liposarcoma cell line:SW 872	10726-110A6	145.23	16.81	5.24	5.24	4.02	0.61
liver, adult, pool1	10018-101C9	79.41	4.21	3.08	5.67	1.30	0.32
liver, fetal, pool1	10086-102B5	42.33	8.47	2.82	0.00	2.82	0.94
locus coeruleus - adult, donor10196	10182-103D2	97.41	23.62	18.37	3.06	2.62	1.17
locus coeruleus, adult, donor10252	10165-103B3	115.53	30.64	16.24	4.98	4.24	0.37
locus coeruleus, adult, donor10258	10375-105G6	135.71	35.27	40.35	3.95	5.92	1.97
locus coeruleus, newborn, donor10223	10362-105F2	113.99	9.67	10.09	4.21	0.84	0.00
lung adenocarcinoma cell line:A549	10499-107C4	50.79	6.78	1.66	1.25	1.25	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	100.65	5.52	0.69	4.14	2.76	2.07
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	158.57	10.94	6.59	6.59	2.11	0.26
lung, adult, pool1	10019-101D1	74.66	7.21	4.84	0.83	0.83	0.59
lung, fetal, donor1	10068-101I5	159.54	16.55	8.28	2.28	0.00	1.43
lung, right lower lobe, adult, donor1	10075-102A3	102.18	12.83	6.87	1.83	0.92	0.46
lymph node, adult, donor1	10077-102A5	69.11	10.41	5.21	0.47	1.42	0.47
lymphangiectasia cell line:DS-1	10727-110A7	56.99	8.11	2.63	0.88	1.32	0.22
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	67.31	10.41	4.23	1.06	0.75	0.30
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	48.42	5.10	1.70	1.70	2.55	0.00
mature adipocyte, donor1	12231-129F8	52.83	1.78	2.66	2.66	2.22	0.00
mature adipocyte, donor2	12232-129F9	70.14	5.81	3.94	2.08	0.62	0.00
mature adipocyte, donor3	12233-129G1	52.87	5.22	1.90	1.19	1.66	0.00
mature adipocyte, donor4	12234-129G2	70.28	4.74	3.16	2.37	1.84	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	171.31	15.96	10.01	12.63	3.10	0.95
medial frontal gyrus - adult, donor10196	10170-103B8	162.44	25.94	21.43	1.13	2.26	3.38
medial frontal gyrus, adult, donor10252	10150-102I6	141.42	28.14	15.82	3.13	2.94	1.66
medial frontal gyrus, adult, donor10258	10368-105F8	126.76	27.64	20.33	1.27	1.27	0.95
medial frontal gyrus, newborn, donor10223	10352-105E1	105.34	6.82	8.10	4.69	0.85	1.28
medial temporal gyrus - adult, donor10196	10183-103D3	187.99	27.51	21.60	3.38	1.86	3.21
medial temporal gyrus, adult, donor10252	10156-103A3	140.92	25.47	12.10	4.03	5.09	1.06
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	73.20	15.41	28.89	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	157.89	0.00	0.00	0.00	287.07	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	168.70	10.41	13.28	2.51	0.72	1.08
medulla oblongata - adult, donor10196	10174-103C3	68.14	9.09	12.33	3.24	1.30	1.30
medulla oblongata, adult, donor10252	10155-103A2	111.92	26.94	14.40	3.25	1.55	1.39
medulla oblongata, adult, pool1	10038-101F2	159.58	26.45	16.90	6.29	3.10	2.04
medulla oblongata, newborn, donor10223	10361-105F1	76.03	10.07	11.11	3.47	1.04	2.08
medulloblastoma cell line:D283 Med	10838-111E1	440.39	57.12	40.08	2.21	3.54	0.44
medulloblastoma cell line:ONS-76	10759-110E3	78.13	12.84	8.31	2.69	1.22	0.12
melanoma cell line:COLO 679	10514-107E1	127.36	17.25	7.19	11.07	5.89	0.86
melanoma cell line:G-361	10465-106H6	52.94	5.70	1.90	3.26	0.54	0.27
meningioma cell line:HKBMM	10691-109F7	56.44	4.70	2.53	0.54	1.81	0.00
merkel cell carcinoma cell line:MKL-1	10843-111E6	261.70	31.72	18.50	0.88	2.64	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	309.77	52.36	31.37	14.52	7.78	0.26
mesenchymal precursor cell - adipose, donor1	11747-123G1	87.92	5.83	2.30	2.76	3.07	0.15
mesenchymal precursor cell - adipose, donor2	11748-123G2	62.90	2.54	0.91	3.27	1.09	0.18
mesenchymal precursor cell - adipose, donor3	11749-123G3	59.22	4.56	3.31	1.24	1.24	0.41
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	62.37	5.62	1.40	2.25	1.26	0.28
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	51.99	7.51	0.96	1.93	2.31	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	56.22	5.55	3.47	1.39	0.69	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	49.60	3.60	1.89	0.86	0.34	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	63.37	5.52	1.96	1.73	1.27	0.23
mesenchymal precursor cell - cardiac, donor3	11754-123G8	78.39	6.50	3.18	3.18	1.59	0.13
mesenchymal precursor cell - cardiac, donor4	11755-123G9	70.90	6.62	3.65	3.92	2.03	0.41
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	75.68	6.97	3.27	4.41	1.85	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	66.53	4.94	3.29	1.65	0.99	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	89.66	6.78	2.91	4.01	1.52	0.42
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	67.02	4.19	3.14	3.49	0.35	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	46.14	3.06	1.22	2.25	2.25	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	76.56	7.19	2.16	2.16	0.00	0.36
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	50.17	3.93	1.45	2.07	0.93	0.10
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	46.05	6.61	4.33	3.42	1.14	0.46
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	74.26	6.71	1.68	2.10	1.68	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	68.29	4.93	3.29	2.69	0.60	0.30
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	66.79	6.56	2.28	3.15	1.49	0.26
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	55.22	5.89	3.31	3.31	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	68.68	3.43	4.29	3.72	0.86	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	130.09	10.95	10.10	2.11	5.47	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	69.41	5.94	3.65	1.37	0.91	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	76.74	4.86	4.09	2.30	1.53	0.51
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	75.91	6.02	1.57	1.31	1.83	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	87.80	6.16	4.93	6.16	1.85	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	74.84	4.24	3.77	3.06	1.65	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	75.48	5.08	3.05	1.02	1.35	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	72.31	3.54	2.75	1.96	1.57	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	74.61	4.17	3.71	2.32	1.39	0.93
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	96.61	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	83.35	6.06	3.46	2.88	0.87	0.29
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	83.22	4.91	4.46	2.68	1.78	0.45
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	93.74	7.45	4.33	2.40	1.68	0.48
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	85.80	5.13	3.67	3.67	1.47	0.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	74.18	3.36	3.36	3.02	1.01	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	69.59	4.50	4.50	4.50	1.23	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	70.02	4.30	2.58	2.58	1.29	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	68.36	8.20	2.73	5.47	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	51.65	0.00	0.00	5.16	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	75.35	5.52	1.95	2.92	0.32	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	80.02	5.82	1.45	1.45	1.45	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	74.63	4.26	4.26	2.67	0.53	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	67.87	5.72	2.45	1.64	0.82	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	69.58	5.05	1.55	3.11	1.94	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	54.57	2.10	2.10	2.10	4.20	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	55.63	3.97	1.99	0.99	0.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	95.34	4.77	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	58.70	3.56	2.37	4.74	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	62.14	4.87	1.22	2.44	3.66	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	81.16	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	69.67	5.07	3.17	4.43	1.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	67.60	3.45	2.76	2.41	1.03	1.38
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	49.43	2.15	2.15	4.30	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	39.92	3.99	3.99	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	24.11	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	53.38	2.85	2.04	0.81	1.63	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	49.26	9.53	1.59	0.00	1.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	44.80	3.54	1.18	1.77	1.77	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	47.69	3.74	3.43	1.56	1.87	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	54.80	4.01	2.67	0.00	1.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	52.04	5.91	0.00	1.18	3.55	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	38.52	2.57	10.27	2.57	2.57	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	54.38	1.38	3.44	2.07	1.38	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	61.85	10.39	1.98	4.45	1.98	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	59.44	5.61	1.12	2.24	3.36	1.12
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	66.15	3.18	3.82	8.27	1.27	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	70.93	8.46	4.84	2.82	3.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	67.60	6.54	6.54	2.18	2.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	68.42	7.60	2.53	5.07	2.53	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	67.97	12.14	3.64	1.82	1.82	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	58.75	9.04	9.04	13.56	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	59.30	6.59	1.65	4.94	4.12	0.82
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	62.31	5.36	2.58	3.97	0.99	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	65.87	4.22	2.92	2.92	1.62	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	66.21	5.09	2.04	3.06	2.04	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	94.39	3.87	2.32	6.19	0.77	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	85.99	17.25	4.25	0.94	2.60	0.24
mesothelioma cell line:ACC-MESO-4	10494-107B8	122.79	6.72	2.09	7.41	1.85	0.70
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	115.39	12.82	0.00	4.27	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	54.35	6.17	2.77	4.01	2.47	0.72
mesothelioma cell line:Mero-25	10850-111F4	84.43	13.39	4.99	1.82	0.23	0.00
mesothelioma cell line:Mero-41	10851-111F5	78.97	6.11	4.40	0.49	0.49	0.24
mesothelioma cell line:Mero-48a	10852-111F6	132.42	15.50	5.76	4.43	1.55	0.66
mesothelioma cell line:Mero-82	10853-111F7	89.88	11.56	4.99	4.47	2.37	0.00
mesothelioma cell line:Mero-83	10854-111F8	139.58	14.98	9.70	4.77	2.04	0.17
mesothelioma cell line:Mero-84	10855-111F9	94.28	8.85	3.79	3.54	4.30	0.51
mesothelioma cell line:Mero-95	10856-111G1	114.08	10.35	7.66	3.52	2.07	0.00
mesothelioma cell line:NCI-H2052	10847-111F1	115.79	11.60	7.12	3.98	1.49	0.33
mesothelioma cell line:NCI-H226	10846-111E9	83.62	10.14	2.71	4.89	1.99	0.18
mesothelioma cell line:NCI-H2452	10848-111F2	78.58	5.47	5.12	2.22	1.88	0.68
mesothelioma cell line:NCI-H28	10845-111E8	90.59	7.89	6.36	2.54	0.76	0.00
mesothelioma cell line:No36	10857-111G2	79.27	7.83	7.18	1.63	0.33	0.65
mesothelioma cell line:ONE58	10858-111G3	81.29	6.77	4.06	4.34	1.35	0.00
migratory langerhans cells, donor1	11901-125F2	59.50	2.88	1.34	0.00	0.38	0.19
migratory langerhans cells, donor2	11902-125F3	78.15	2.56	1.59	1.22	0.85	0.37
migratory langerhans cells, donor3	11903-125F4	89.20	5.03	4.85	0.54	0.90	0.18
mixed mullerian tumor cell line:HTMMT	10689-109F5	133.86	19.26	5.88	0.98	4.90	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	67.61	8.27	1.91	2.12	2.54	0.00
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	56.90	9.68	1.38	2.30	1.15	0.23
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	85.63	9.70	4.00	3.43	2.85	0.57
myelodysplastic syndrome cell line:SKM-1	10772-110F7	117.71	15.34	7.76	0.55	3.51	0.55
myeloma cell line:PCM6	10474-106I6	41.91	3.95	0.79	0.79	1.78	0.20
myxofibrosarcoma cell line:MFH-ino	10600-108E6	72.54	9.13	2.54	1.52	1.52	0.51
myxofibrosarcoma cell line:NMFH-1	10684-109E9	69.04	7.65	2.35	1.18	0.98	0.20
nasal epithelial cells, donor1, tech_rep1	12226-129F3	34.54	9.81	3.57	0.56	1.34	0.56
nasal epithelial cells, donor1, tech_rep2	12226-129F3	32.28	6.99	3.75	0.37	1.10	0.66
nasal epithelial cells, donor2	12227-129F4	53.54	8.28	3.86	2.76	0.00	1.10
neuroblastoma cell line:CHP-134	10508-107D4	207.51	24.85	16.56	2.76	3.68	0.00
neuroblastoma cell line:NB-1	10539-107G8	228.06	30.49	20.58	14.22	5.05	0.37
neuroblastoma cell line:NBsusSR	10607-108F4	35.01	5.06	2.32	0.63	0.84	0.21
neuroblastoma cell line:NH-12	10555-107I6	173.68	25.53	12.67	2.98	0.93	0.00
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	156.33	17.08	9.96	0.95	0.71	0.24
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	203.52	21.38	8.55	3.96	6.81	0.32
neuroectodermal tumor cell line:TASK1	10774-110F9	166.84	21.33	10.06	4.43	3.62	0.20
neuroepithelioma cell line:SK-N-MC	10728-110A8	67.39	11.44	6.36	1.27	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	62.28	6.12	1.86	1.33	2.66	0.53
neutrophil PMN, donor1	12133-128D9	163.62	14.87	14.87	14.87	0.00	0.00
neutrophil PMN, donor2	12137-128E4	26.56	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	104.18	9.47	0.00	0.00	9.47	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	245.22	23.68	10.99	7.10	2.37	0.00
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	186.52	13.61	8.81	4.80	1.60	0.80
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	83.36	8.98	3.85	1.92	2.24	0.64
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	84.35	6.57	3.42	4.47	3.42	0.53
nucleus accumbens, adult, pool1	10037-101F1	226.85	36.75	27.56	5.16	2.44	3.66
occipital cortex - adult, donor10196	10172-103C1	148.35	22.66	30.91	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	129.35	24.42	11.54	2.15	6.17	1.34
occipital cortex, newborn, donor10223	10355-105E4	178.33	14.19	16.01	4.73	1.09	0.36
occipital lobe, adult, donor1	10076-102A4	236.68	42.51	32.01	4.72	2.36	4.20
occipital lobe, fetal, donor1	10073-102A1	332.98	37.33	36.47	8.58	2.57	2.57
occipital pole, adult, pool1	10036-101E9	231.64	35.64	26.73	4.89	2.05	4.34
olfactory region, adult	10195-103E6	161.44	28.08	22.16	4.97	1.72	1.53
optic nerve, donor1	10277-104E7	148.08	14.01	6.00	0.00	4.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	86.91	9.11	3.42	1.71	0.68	0.46
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	69.93	9.89	5.08	0.69	2.20	0.27
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	69.42	8.64	5.25	3.22	0.51	0.34
oral squamous cell carcinoma cell line:SAS	10544-107H4	81.90	8.32	4.97	1.73	0.69	0.35
osteoclastoma cell line:Hs 706.T	10704-109H2	97.30	8.23	5.88	4.41	2.35	0.29
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	95.30	4.67	1.87	5.61	1.87	0.93
osteosarcoma cell line:HS-Os-1	10558-107I9	0.00	0.00	0.00	0.00	0.00	0.00
ovary, adult, pool1	10020-101D2	105.35	14.59	10.31	1.31	0.61	0.70
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	36.30	6.60	2.93	1.28	1.28	0.18
pancreas, adult, donor1	10049-101G4	77.13	7.53	4.70	4.70	4.70	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	101.47	9.78	5.31	0.84	2.24	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	100.17	16.69	8.01	2.21	2.04	1.19
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	70.21	7.78	3.81	2.15	1.32	0.17
paracentral gyrus, adult, pool1	10035-101E8	215.63	36.61	30.66	3.57	2.47	3.11
parietal cortex, adult, donor10258	10373-105G4	111.57	22.75	19.82	0.73	0.00	2.20
parietal lobe - adult, donor10196	10171-103B9	123.20	15.99	16.93	0.00	1.88	0.94
parietal lobe, adult, donor10252	10157-103A4	129.12	36.20	16.53	1.14	3.14	3.71
parietal lobe, adult, pool1	10034-101E7	209.02	35.78	27.41	5.55	2.64	4.14
parietal lobe, fetal, donor1	10072-101I9	257.98	36.85	26.19	9.70	1.94	5.82
parietal lobe, newborn, donor10223	10356-105E5	174.97	11.22	11.96	4.86	0.37	0.37
parotid gland, adult	10199-103F1	62.90	6.17	1.85	0.62	0.00	0.00
penis, adult	10200-103F2	103.13	5.37	5.91	1.61	0.54	1.61
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	106.91	15.80	8.74	0.37	1.86	0.37
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	52.45	8.45	3.06	2.19	1.60	0.00
pineal gland - adult, donor10196	10179-103C8	115.46	31.61	26.45	1.29	0.00	3.87
pineal gland, adult, donor10252	10160-103A7	201.94	56.85	42.05	8.29	2.37	2.37
pineal gland, adult, donor10258	10377-105G8	172.45	41.39	25.08	4.39	1.88	4.39
pituitary gland - adult, donor10196	10180-103C9	144.69	21.25	24.28	0.00	0.00	4.05
pituitary gland, adult, donor10252	10162-103A9	189.71	40.13	26.06	2.08	1.56	7.30
pituitary gland, adult, donor10258	10378-105G9	150.67	24.69	11.92	0.85	1.70	0.85
placenta, adult, pool1	10021-101D3	94.28	7.63	5.38	1.18	0.86	0.86
plasma cell leukemia cell line:ARH-77	10840-111E3	45.82	5.03	3.44	0.53	0.66	0.13
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	61.17	4.67	1.71	4.82	2.33	0.31
pons, adult, pool1	10033-101E6	140.81	25.30	25.65	4.13	2.32	3.27
postcentral gyrus, adult, pool1	10032-101E5	247.14	39.75	27.81	5.23	4.62	3.57
promyelocytes/myelocytes PMC, donor1	12132-128D8	194.50	8.37	8.37	10.46	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	77.11	0.00	5.51	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	35.21	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	94.97	10.05	4.95	1.75	2.18	0.00
prostate cancer cell line:PC-3	10439-106E7	84.94	10.16	5.63	1.27	1.63	0.18
prostate, adult, pool1	10022-101D4	89.69	8.43	4.99	1.63	1.36	0.73
putamen, adult, donor10196	10176-103C5	245.74	55.00	29.04	2.12	6.14	3.30
putamen, adult, donor10252	10152-102I8	109.80	19.61	5.88	9.80	3.92	1.96
putamen, adult, donor10258, tech_rep1	10372-105G3	72.13	28.41	22.95	1.09	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	137.72	26.82	19.57	1.21	1.69	0.97
putamen, newborn, donor10223	10365-105F5	121.45	8.25	7.50	3.00	0.00	2.25
rectal cancer cell line:TT1TKB	10469-106I1	57.90	9.89	3.20	1.45	1.16	0.29
rectum, fetal, donor1	10067-101I4	137.71	19.47	12.52	1.39	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	85.01	4.88	2.33	1.48	0.21	0.21
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	27.34	2.90	2.49	0.00	0.83	0.00
retina, adult, pool1	10030-101E3	158.05	18.09	11.53	3.08	2.09	1.39
retinoblastoma cell line:Y79	10475-106I7	166.79	27.80	17.15	4.68	5.46	0.26
rhabdomyosarcoma cell line:KYM-1	10787-110H4	76.60	10.33	6.15	2.09	3.20	0.25
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	142.01	15.75	6.75	3.94	4.22	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	66.69	5.30	0.76	0.76	3.03	0.00
salivary acinar cells, donor1	11771-123I7	73.97	6.96	5.50	2.10	0.49	0.32
salivary acinar cells, donor2	11772-123I8	98.17	7.71	4.41	1.93	0.28	0.41
salivary acinar cells, donor3	11773-123I9	59.58	5.96	3.97	0.00	1.99	0.00
salivary gland, adult, pool1	10093-102C3	86.36	8.58	6.29	0.00	1.14	1.14
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	78.92	9.19	5.82	1.69	0.67	0.17
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	62.77	8.58	5.41	1.06	0.47	0.47
seminal vesicle, adult	10201-103F3	116.92	8.47	1.06	4.76	0.53	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	57.82	6.07	1.94	4.62	0.73	0.00
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	27.18	2.26	2.01	1.51	0.25	0.25
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	65.23	6.02	1.00	2.01	1.00	2.01
serous cystadenocarcinoma cell line:HTOA	10693-109F9	65.95	10.21	5.64	1.88	0.67	0.27
signet ring carcinoma cell line:Kato III	10436-106E4	91.74	8.62	4.64	3.87	1.99	0.44
signet ring carcinoma cell line:NUGC-4	10483-107A6	62.84	5.29	1.42	2.71	1.68	1.68
skeletal muscle - soleus muscle, donor1	10282-104F3	129.10	30.50	13.48	0.00	2.13	0.71
skeletal muscle, adult, pool1	10023-101D5	126.65	15.11	8.28	1.44	3.84	0.48
skeletal muscle, fetal, donor1	10066-101I3	104.52	12.06	3.02	1.01	2.01	0.00
skin, adult, donor1	10074-102A2	101.78	0.00	13.57	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	121.83	9.47	6.31	5.68	3.16	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	154.09	19.01	9.34	16.01	3.67	0.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	205.51	18.60	12.61	10.40	3.78	2.21
small cell lung carcinoma cell line:DMS 144	10841-111E4	58.60	8.67	4.43	0.39	0.96	0.00
small cell lung carcinoma cell line:LK-2	10541-107H1	127.58	12.69	4.94	14.83	1.48	1.48
small cell lung carcinoma cell line:NCI-H82	10842-111E5	174.52	55.98	49.54	1.13	1.13	0.80
small cell lung carcinoma cell line:WA-hT	10562-108A4	144.92	22.01	8.93	6.32	1.74	0.87
small intestine, adult, pool1	10024-101D6	88.15	4.30	2.75	4.18	0.84	3.11
small intestine, fetal, donor1	10064-101I1	88.20	5.90	4.42	1.72	0.98	0.98
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	85.65	7.69	2.56	14.87	2.05	0.51
smooth muscle, adult, pool1	10048-101G3	71.85	8.79	5.43	0.78	1.29	0.52
somatostatinoma cell line:QGP-1	10781-110G7	146.88	16.62	6.70	7.50	2.68	0.54
spinal cord - adult, donor10196	10181-103D1	86.03	18.12	14.45	3.21	2.75	1.15
spinal cord, adult, donor10252	10159-103A6	90.29	16.95	7.89	2.76	1.58	0.39
spinal cord, adult, donor10258	10369-105F9	59.49	13.14	10.38	0.69	0.00	0.00
spinal cord, fetal, donor1	10056-101H2	183.56	34.15	25.61	8.54	4.27	1.22
spinal cord, newborn, donor10223	10359-105E8	72.10	3.67	9.64	5.05	0.92	0.46
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	60.19	6.72	5.23	2.39	1.64	0.75
spleen, adult, pool1	10025-101D7	81.50	7.60	4.07	2.09	1.87	0.55
spleen, fetal, pool1	10044-101F8	125.94	12.95	6.59	3.73	0.95	0.64
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	82.81	5.69	3.31	1.24	0.83	0.31
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	99.87	11.01	6.27	2.09	3.23	0.19
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	82.47	8.39	6.99	2.80	1.05	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	59.03	8.21	3.13	3.91	0.39	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	101.08	14.29	6.42	3.26	2.14	1.91
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	127.93	14.40	8.47	8.90	0.85	0.42
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	203.92	12.27	4.65	4.23	0.85	2.12
stomach, fetal, donor1	10062-101H8	115.34	7.48	3.20	2.14	3.20	0.00
submaxillary gland, adult	10202-103F4	80.32	6.84	2.85	2.28	0.00	0.00
substantia nigra - adult, donor10196	10178-103C7	162.82	54.27	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	109.88	18.90	7.48	4.15	5.19	1.45
substantia nigra, adult, donor10258	10371-105G2	77.59	20.17	40.35	2.59	0.00	0.52
substantia nigra, newborn, donor10223	10358-105E7	76.31	8.48	8.48	7.77	0.00	0.71
synovial sarcoma cell line:HS-SY-II	10441-106E9	116.24	10.78	6.42	2.98	0.46	0.69
temporal lobe, adult, pool1	10031-101E4	267.79	39.76	28.74	5.59	3.56	3.98
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	313.40	31.34	22.79	10.68	5.70	0.71
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	341.96	24.61	21.54	11.87	2.64	2.20
tenocyte, donor1	11763-123H8	91.81	7.33	3.14	1.05	3.49	1.75
tenocyte, donor2	11765-123I1	82.41	8.01	3.05	2.67	3.43	0.76
tenocyte, donor3	11768-123I4	73.39	7.41	5.93	2.22	3.71	0.37
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	131.21	36.71	24.13	3.40	3.40	0.17
teratocarcinoma cell line:NCR-G1	10798-110I6	100.66	16.96	6.47	3.70	1.85	0.00
teratocarcinoma cell line:PA-1	10807-111A6	109.26	16.12	10.54	5.89	4.03	0.31
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	194.61	40.50	26.02	12.44	3.17	0.89
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	226.90	31.77	23.82	4.54	1.89	1.13
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	101.86	16.47	6.11	4.25	1.09	0.65
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	148.19	21.17	16.61	3.26	3.91	0.65
testis, adult, pool1	10026-101D8	94.38	12.24	9.45	4.51	1.29	0.54
testis, adult, pool2	10096-102C6	111.42	21.65	32.03	5.86	1.80	0.45
thalamus - adult, donor10196	10168-103B6	70.66	26.50	17.66	3.31	2.21	2.21
thalamus, adult, donor10252	10154-103A1	124.09	25.01	10.16	4.69	3.28	1.56
thalamus, adult, donor10258, tech_rep1	10370-105G1	69.28	27.71	30.79	3.08	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	73.62	18.94	18.61	1.48	3.79	0.66
thalamus, newborn, donor10223	10366-105F6	59.83	9.78	11.51	2.30	1.73	0.58
throat, adult	10209-103G2	99.37	11.24	6.49	2.75	0.00	1.75
throat, fetal, donor1	10061-101H7	111.22	9.75	6.70	4.57	3.96	0.91
thymic carcinoma cell line:Ty-82	10803-111A2	200.32	11.92	9.94	8.55	2.58	0.60
thymus, adult, pool1	10027-101D9	200.62	14.81	7.75	1.69	1.99	2.68
thymus, fetal, pool1	10043-101F7	195.34	22.44	8.83	1.87	0.52	3.95
thyroid carcinoma cell line:KHM-5M	10776-110G2	64.35	5.58	2.26	1.99	2.39	0.66
thyroid carcinoma cell line:TCO-1	10783-110G9	139.97	25.28	12.29	3.35	3.91	0.70
thyroid, adult, pool1	10028-101E1	105.07	11.94	6.72	2.33	1.59	1.03
thyroid, fetal, donor1	10060-101H6	113.38	16.08	11.60	4.22	3.95	0.79
tongue epidermis (fungiform papillae), donor1	10288-104F9	80.07	6.16	0.00	0.00	0.00	0.00
tongue, adult	10203-103F5	100.94	6.51	5.81	1.40	2.09	0.23
tongue, fetal, donor1	10059-101H5	89.85	18.13	6.70	1.18	6.31	1.97
tonsil, adult, pool1	10047-101G2	129.33	9.62	6.61	2.40	0.50	1.40
trachea, adult, pool1	10029-101E2	76.81	8.43	3.52	2.29	0.74	0.57
trachea, fetal, donor1	10058-101H4	72.71	8.85	2.69	2.69	2.31	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	84.32	4.25	3.19	3.54	3.54	0.35
transitional-cell carcinoma cell line:5637	10418-106C4	105.27	12.56	9.02	3.85	1.11	0.30
transitional-cell carcinoma cell line:JMSU1	10492-107B6	87.27	8.93	4.39	1.72	2.19	0.47
tridermal teratoma cell line:HGRT	10694-109G1	58.98	5.71	0.00	0.00	1.90	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	59.42	4.23	2.29	3.98	1.02	0.17
umbilical cord, fetal, donor1	10057-101H3	83.46	4.17	2.09	4.17	0.00	0.00
uterus, adult, pool1	10100-102D1	141.62	12.29	7.51	1.71	0.17	1.02
uterus, fetal, donor1	10055-101H1	102.39	9.21	4.10	4.61	6.66	0.51
vagina, adult	10204-103F6	79.48	17.45	6.46	1.94	2.58	0.65
vein, adult	10191-103E2	106.09	7.23	2.41	2.41	0.88	0.44
xeroderma pigentosum b cell line:XPL 17	10563-108A5	45.93	4.54	1.87	0.00	0.80	0.00